Collagen

PubMed ID: 15713726

Larger early reductions in collagen-breakdown marker NTx predicted greater multi‑year BMD gains on osteoporosis therapy (marker→BMD link).

PubMed ID: 15312252

ISMO produced large decreases in a collagen-derived bone resorption marker (NTx) and increased bone formation marker (BSALP) — directly relevant to bone strength.

PubMed ID: 16410328

Same ISMO pilot showing substantial reductions in bone resorption markers and increases in formation markers — strong indirect evidence about bone/collagen metabolism.

PubMed ID: 18547426

Intervention (ch-OSA) increased PINP (type I procollagen marker) and produced a small femoral BMD benefit in subgroup—evidence linking collagen metabolism to bone density.

PubMed ID: 17896582

AKG‑Ca lowered CTX by ~37% and tended to preserve lumbar spine BMD—direct, large effect on bone collagen turnover and BMD.

PubMed ID: 30087216

RCT in hemodialysis patients showed ~17% reduction in serum NTx (bone collagen breakdown) vs control — supports reduced bone collagen resorption.

PubMed ID: 21636012

Multi-nutrient RCT increased bone biomarkers and subgroup rise in type I collagen propeptide—moderate evidence for bone-supporting effects.

PubMed ID: 2023034

Collagraft (fibrillar collagen bone graft substitute) performed comparably to autograft for long‑bone fracture healing—direct application of collagen to bone repair.

PubMed ID: 7703621

Randomized trial: an ossein‑hydroxyapatite product (contains collagen) slowed trabecular bone loss vs calcium over 20 months—direct bone‑preserving effect.

PubMed ID: 9111393

Bovine-collagen + calcium‑phosphate graft achieved fracture union equivalent to autograft—direct biomaterial/collagen evidence for bone/healing support.

PubMed ID: 9284739

Short‑term bisphosphonate therapy produced large rapid reductions in urinary collagen‑derived telopeptides, reflecting strong antiresorptive/bone‑protective action.

PubMed ID: 9522323

Combined HRT significantly decreased bone collagen formation/resorption markers (PICP, ICTP), consistent with bone‑protective effects.

PubMed ID: 9240732

Intermittent IV bisphosphonate therapy slowed postmenopausal bone loss and reduced collagen turnover markers.

PubMed ID: 8996134

Bisphosphonates (pamidronate/clodronate) in hypercalcemia strongly lowered collagen telopeptides — demonstrates powerful suppression of collagen resorption markers.

PubMed ID: 9209198

Large trial showing urinary NTx (a collagen telopeptide) tracked and predicted BMD response to HRT — directly linking collagen markers to bone mass outcomes.

PubMed ID: 9738515

Alendronate produced large BMD gains and marked decreases in collagen-derived resorption markers—strong demonstration that changing collagen turnover affects bone strength.

PubMed ID: 9737352

Vitamin K2 (MK‑4) produced significant improvements in hemiplegic‑side BMD and favorable changes in collagen-related marker ICTP.

PubMed ID: 10550467

Large alendronate RCT increased BMD at 12 months in postmenopausal women with low bone mass — strong bone-strength evidence.

PubMed ID: 10064126

Hormone therapy plus calcium produced early decreases in urinary collagen crosslinks and 2-year increases in spine/hip BMD.

PubMed ID: 11000341

Alendronate produced large (≈+5.8% spine) BMD increases and a 75% decrease in urinary NTx — strong bone outcome.

PubMed ID: 10769437

Alfacalcidol prevented steroid-related suppression of collagen-synthesis markers and protected BMD vs calcium alone.

PubMed ID: 10979796

Large RCT showing alendronate increased BMD and reduced fractures — directly evidences stronger bones (though not a collagen supplement).

PubMed ID: 11127214

Etidronate reduced hemiplegic-side bone loss and lowered collagen-resorption markers — supports bone preservation.

PubMed ID: 10690882

Large RCT: alendronate and estrogen substantially increased BMD and lowered collagen-resorption markers.

PubMed ID: 11062356

Alendronate increased spine/hip BMD and rapidly reduced collagen-breakdown markers in women.

PubMed ID: 10996576

Large trial: salmon calcitonin reduced vertebral fractures and modestly increased spine BMD.

PubMed ID: 10865218

Intermittent alendronate regimens prevented bone loss and lowered urinary N-telopeptides.

PubMed ID: 11212161

Alendronate in glucocorticoid-treated patients gave clear spine/hip BMD increases and major reductions in turnover markers—highly relevant to bone strength.

PubMed ID: 11165950

High‑dose risedronate markedly reduced urinary collagen cross‑links (DPyr/Pyr) indicating strong antiresorptive effect on bone collagen.

PubMed ID: 12459940

Large RCT: risedronate produced substantial reductions in collagen-resorption markers and large lumbar-spine BMD gains (+4.9%), direct and strong bone-strength evidence.

PubMed ID: 11940726

Alendronate regimen showed clear BMD increases and large reductions in collagen turnover markers (strong bone effect but pharmacologic, not collagen supplement).

PubMed ID: 12050252

Alendronate markedly increased lumbar/spine BMD in African‑American women — good evidence of stronger bone (indirect for collagen supplement).

PubMed ID: 12020302

Hormone therapy produced consistent BMD gains and reduced bone turnover markers in a large RCT—relevant to preserving bone strength with aging.

PubMed ID: 14653832

IV pamidronate added to Ca/vitD raised spine and hip BMD in Crohn's disease more than supplements alone—relevant to bone mass.

PubMed ID: 13678475

Large trial showing alendronate reduced collagen-breakdown marker markedly and increased spine/hip BMD relative to risedronate—strong evidence for bone benefit.

PubMed ID: 14676992

Transdermal estradiol prevented spine bone loss and lowered CTx in osteopenic SLE patients—clear bone-protective effect in this group.

PubMed ID: 12827224

Raloxifene+fluoride produced clear spine/hip BMD gains — relevant to bone-strength benefit though intervention is not collagen supplementation.

PubMed ID: 12854267

Calcium ascorbate (vitamin C) slightly reduced pain/function in OA and vitamin C is needed for collagen synthesis—indirect but plausible bone/connective-tissue relevance.

PubMed ID: 14500804

Parathyroid hormone substantially increased trabecular bone density and bone-formation markers—clear anabolic bone effect.

PubMed ID: 12904840

Nutritional (calorie/protein) drink produced ~32% reduction in CTX and modest hip-BMD trends—meaningful effect on bone turnover and potential bone preservation.

PubMed ID: 12817758

Early large decreases in collagen degradation markers with risedronate were tightly linked to fracture risk reduction—strong indirect bone-strength evidence.

PubMed ID: 12641503

Ibandronate and sodium fluoride increased spine BMD in Crohn's patients and lowered a collagen-resorption marker—moderate, disease-specific bone benefit.

PubMed ID: 12590006

Switching/continuing bisphosphonates yielded modest spine/hip BMD gains though collagen cross-links were unchanged—some bone relevance.

PubMed ID: 12862363

Switching to alendronate raised spine BMD and reduced collagen-resorption marker (NTX) — strong bone-strength signal (drug trial).

PubMed ID: 12972476

Quarterly IV ibandronate increased spine/hip BMD in postmenopausal women — direct, large bone-density effect.

PubMed ID: 13678775

IV neridronate produced substantial spine and hip BMD gains over 2 years — highly relevant to stronger-bones outcome.

PubMed ID: 14610642

Raloxifene/HRT lowered turnover markers and preserved/increased BMD vs placebo — supports bone-strength benefit.

PubMed ID: 12886826

Parenteral clodronate reduced bone resorption markers and modestly increased spine/hip BMD over 2 years—moderate bone benefit.

PubMed ID: 15240609

Alendronate in primary hyperparathyroidism gave large BMD increases and pronounced decreases in urinary NTx—direct bone-strength signal.

PubMed ID: 15380045

HRT markedly lowered collagen degradation markers and increased BMD in postmenopausal RA patients.

PubMed ID: 15231012

Continuing alendronate preserved higher BMD and continued suppression of turnover vs stopping.

PubMed ID: 14973216

Alendronate and calcitriol limited post-transplant bone loss relative to untreated controls.

PubMed ID: 14753731

Ibandronate increased spine/hip BMD and lowered bone turnover in early postmenopausal women.

PubMed ID: 15706659

Alendronate produced faster/more frequent BMD gains and bigger early drops in turnover vs risedronate.

PubMed ID: 15316868

Risedronate reduced fracture incidence and produced greater decreases in bone resorption markers vs etidronate — clinically meaningful bone protection.

PubMed ID: 15312255

Oral salmon calcitonin produced large acute reductions in serum CTx and modest 3-month effects — marker changes relevant to bone resorption and bone health.

PubMed ID: 15585774

Nutrient-enriched formula produced large BMC increases in preterm infants (direct bone density outcome).

PubMed ID: 15176987

Anti‑RANKL caused large sustained suppression of collagen-resorption markers → strong mechanistic effect on bone turnover.

PubMed ID: 15562367

Alendronate + Ca/Vit D reduced bone resorption markers and preserved/improved BMD in osteopenic/osteoporotic patients.

PubMed ID: 14962813

Raloxifene produced marked reductions in collagen turnover markers and reduced fracture risk — strong bone benefit signal.

PubMed ID: 15068495

Large RCT: clodronate halved vertebral fracture risk over 3 years — strong clinical bone benefit.

PubMed ID: 15031343

Alfacalcidol increased spine/femoral BMD and reduced markers in chronic renal failure — clinically meaningful.

PubMed ID: 15365658

Calcitonin nasal spray lowered serum CTx and urinary NTx in high-turnover older women.

PubMed ID: 15744450

High-calcium mineral water lowered PTH and serum/urine type‑I collagen telopeptides (~13–16%); direct effect on bone collagen turnover.

PubMed ID: 15952402

Bisphosphonate trial produced large BMD gains and ~38% fall in type I collagen breakdown marker—strong evidence for improving bone strength (drug, not supplement).

PubMed ID: 15797959

Pamidronate sharply lowered collagen breakdown markers and preserved spine/hip BMD after stem‑cell transplant.

PubMed ID: 16076919

Once-weekly alendronate produced substantial spine/hip BMD increases and large reductions in collagen telopeptide in postmenopausal Asian women.

PubMed ID: 15654581

Low‑dose estrogen (±progestin) generally prevented spine/hip bone loss in early postmenopausal women over two years.

PubMed ID: 16713432

Large trial showing major BMD increases and strong changes in type I collagen resorption marker (alendronate+HRT) — high indirect evidence on bone strength.

PubMed ID: 17701771

Randomized trial in osteoporotic women showing clear BMD increases and large reductions in collagen turnover markers—direct, high-relevance to bone strength.

PubMed ID: 18257271

Migu tablet trial reported increased BMD and reduced bone-resorption markers in postmenopausal women (indirect because not a collagen supplement but bone outcomes relevant).

PubMed ID: 17879531

Migu tablet increased BMD and altered bone-regulatory proteins—relevant to bone-strength outcomes though product is multi‑compound.

PubMed ID: 19001206

Large RCT: 1200 mg calcium/day increased BMD and reduced a procollagen marker over 2 years—direct bone-strength evidence (non-collagen supplement).

PubMed ID: 18349061

Randomized trial showing ↑lumbar-spine BMD and large rise in bone formation marker (direct bone-strength evidence).

PubMed ID: 18946626

Large randomized trial: neridronate increased BMD and strongly suppressed bone turnover markers—direct, strong evidence for improving bone strength (drug not collagen supplement).

PubMed ID: 19040000

Alendronate plus calcium prevented bone loss and increased BMD vs calcium alone—clear effect on bone strength (drug intervention).

PubMed ID: 18572334

Low‑dose weekly alendronate produced marked suppression of CTX (collagen-derived bone resorption marker) — supports bone-preserving effects (drug).

PubMed ID: 18306478

Alendronate produced larger increases in lumbar BMD and larger reductions in urinary NTX vs raloxifene—direct bone outcome (drug study).

PubMed ID: 19100422

Alendronate in renal transplant recipients increased femoral neck BMD and reduced serum NTx—directly relevant to bone strength (drug).

PubMed ID: 18260172

IV ibandronate produced substantial spine/hip BMD gains and big reductions in CTX—direct, strong bone-strength evidence (drug trial).

PubMed ID: 18950736

Monthly oral ibandronate prevented spine/hip bone loss and reduced resorption markers—direct relevance to increasing/maintaining bone mass.

PubMed ID: 19301089

Risedronate + Ca/VitD lowered RANKL and raised OPG with clear bone-turnover improvements—relevant to bone preservation/strength.

PubMed ID: 19172341

Supplement (lactoferrin/ribonuclease) reduced bone-resorption markers and increased formation markers over 6 months—supplement trial with positive bone biochemical effects (not collagen supplement but relevant).

PubMed ID: 19892499

Direct RCT of oral collagen hydrolysate on bone turnover in postmenopausal women — highest direct relevance (although no benefit found).

PubMed ID: 19855926

IV ibandronate increased BMD and strongly suppressed CTX over 1 year (direct antiresorptive/BMD effect).

PubMed ID: 19343272

Weekly alendronate increased spine BMD and reduced urinary NTx (classic osteoporosis drug result).

PubMed ID: 19877063

Teriparatide produced substantial spine/hip BMD increases and fewer fractures (strong bone outcome).

PubMed ID: 21187295

Raloxifene + supplements increased spine/hip BMD — direct bone-strength evidence.

PubMed ID: 20827548

Teriparatide produced consistent spine BMD increases → strong bone-strength evidence.

PubMed ID: 21672334

Alendronate + alfacalcidol increased BMD and decreased CTX → strong bone benefit.

PubMed ID: 21648282

Daily oral hydrolyzed collagen in children changed bone remodeling biomarkers (IGF‑1, bALP, TRAP) — direct evidence that ingested collagen affects bone biology.

PubMed ID: 21557757

Cross-linked collagen membranes yielded significantly greater crestal mineralized tissue gain vs controls.

PubMed ID: 21927920

Denosumab produced rapid decreases in CTX and dose-related BMD increases → strong bone benefit.

PubMed ID: 23064476

Direct RCT showing preserved lumbar BMD and blunted CTX rise with alendronate+calcitriol—clear bone‑strength/protection signal.

PubMed ID: 22644348

Vitamin D/calcium‑fortified milk produced rapid, sustained reductions in CTX and improved 25(OH)D—favors reduced collagen bone resorption.

PubMed ID: 23163915

Collagen-containing demineralized bovine bone grafts better preserved alveolar ridge dimensions—local bone preservation evidence.

PubMed ID: 22803768

Ibandronate increased spine/hip BMD and reduced sCTX/P1NP in glucocorticoid users—strong bone outcome drug trial.

PubMed ID: 22777865

Long‑term odanacatib produced large spine/hip BMD gains and suppressed resorption markers—indirect evidence linking collagen degradation to bone mass.

PubMed ID: 23040208

Alendronate prevented spine/hip BMD loss and lowered resorption markers—strong bone‑protective drug data (mechanistically linked to collagen turnover).

PubMed ID: 24064689

Odanacatib produced modest BMD gains and altered collagen turnover markers—evidence of bone mass benefit via collagenase inhibition.

PubMed ID: 23653431

Vitamin D/calcium‑fortified yogurt raised 25OHD and reduced CTX/TRAP5b in elderly women—reduces collagen‑derived bone resorption markers.

PubMed ID: 22968256

Alendronate (low/standard) increased BMD and reduced CTX—clear bone outcome evidence (drug trial).

PubMed ID: 25314004

Direct RCT of a calcium–collagen chelate showing significant attenuation of whole-body BMD loss and favorable bone-turnover marker changes in osteopenic postmenopausal women.

PubMed ID: 25792492

Weekly risedronate prevented bone loss and increased spine/hip BMD (robust bone‑strength outcome; drug, not collagen supplement).

PubMed ID: 26961287

Porous hydroxyapatite/type I collagen composite accelerated radiographic bone regeneration vs control (direct collagen implant evidence).

PubMed ID: 29337906

12-month RCT of 5 g collagen peptides increased lumbar spine and femoral neck BMD and raised bone formation marker (direct strong evidence).

PubMed ID: 32131366

3-month RCT adding collagen peptides to Ca+vitD changed bone turnover (P1NP decreased; trend in CTX) in osteopenic postmenopausal women (direct, moderate evidence).

PubMed ID: 34980546

Randomized trial: oral collagen peptides + Ca/VitD increased trabecular/cortical bone parameters vs control over 12 months.

PubMed ID: 33848764

HAp‑collagen bone substitute RCT showed lower recurrence and similar function vs autograft—direct clinical evidence that a collagen-containing bone graft supports bone repair.

PubMed ID: 34040361

Stentoplasty using HAP/collagen filler promoted bone regrowth on CT and durable pain relief (collagen-containing bone filler supports bone healing).

PubMed ID: 37843657

Socket preservation using scaffolds and collagen membranes + rhBMP‑2 produced more new bone at 6 weeks—collagen used as scaffold supporting bone formation.

PubMed ID: 38520382

High‑dose vitamin D RCT preserved/increased hip BMD in men on ADT—strong bone outcome (indirect to dietary collagen but relevant to bone-strength benefit).

PubMed ID: 40042722

Zoledronic acid RCT produced clear BMD increases and favorable bone‑marker changes (strong clinical evidence for bone strengthening; not a collagen supplement).

PubMed ID: 12956481

Hydroxyapatite–collagen–chondroitin filler produced substantially more new bone-like tissue in human defects—direct bone-regeneration evidence (implant context).

PubMed ID: 8675554

Tibolone increased spine/forearm BMD and altered collagen turnover markers—supports bone-strength outcomes.

PubMed ID: 8927288

Alendronate RCT showed increased lumbar BMD and decreased collagen cross-links — direct bone-strength outcome (drug, not collagen supplement) but relevant to collagen-related bone health.

PubMed ID: 8758248

Clodronate in myeloma markedly lowered type I collagen synthesis/degradation markers and is associated with bone effects — relevant to bone/collagen metabolism (drug study).

PubMed ID: 9666879

Alendronate increased spine/hip BMD (direct bone-strength outcome) — high relevance to 'stronger bones' though not collagen supplementation.

PubMed ID: 9685512

Alendronate lowered a type‑I collagen resorption marker (NTx) — supports reduced bone collagen loss and bone strength indirectly.

PubMed ID: 9640412

GH increased collagen-crosslink and bone-formation markers with improved BMD after 12 months — directly bone-relevant but drug intervention.

PubMed ID: 10404804

Large alendronate trial: early decreases in collagen turnover markers predicted later BMD gains—strong biomarker→BMD link.

PubMed ID: 10529464

Alendronate produced large, sustained BMD increases and lowered collagen turnover markers — strong bone effect, but drug-mediated (indirect relevance to oral collagen).

PubMed ID: 11128923

Collagen membrane promoted guided bone regeneration around implants (measurable defect reduction) → direct biomaterial evidence for bone repair/strengthening.

PubMed ID: 10992173

Large RCT: estradiol regimens produced large BMD gains and major reductions in collagen-resorption markers → direct evidence for stronger bone.

PubMed ID: 11061497

Alendronate produced large, sustained reductions in collagen resorption markers that predicted vertebral BMD gains → strong indirect evidence on bone strength.

PubMed ID: 10843152

Alendronate vs calcitonin: substantially greater spine/trochanter BMD increases and large N-telopeptide reductions → supports bone-strength outcomes.

PubMed ID: 10770187

Large alendronate trial showing clear BMD gains — strong bone outcome but unrelated to collagen supplementation (indirect relevance).

PubMed ID: 10746426

Once‑weekly alendronate produced clinically meaningful BMD increases — demonstrates bone strengthening though via a bisphosphonate, not collagen.

PubMed ID: 11288794

Alendronate decreased urinary NTx and preserved/improved alveolar bone height in diabetics—direct evidence of reducing bone collagen loss.

PubMed ID: 11846327

Hormone therapy increased BMD and reduced type I collagen breakdown markers—indirect evidence linking collagen turnover to stronger bone.

PubMed ID: 11283917

Zoledronic acid produced clear, clinically significant increases in spine BMD and reduced bone resorption — strong bone outcome (drug study, not collagen supplement).

PubMed ID: 11388472

Small RCT of milk basic protein increased calcaneus BMD and reduced urinary type I collagen telopeptides — direct evidence of bone-strengthening effect.

PubMed ID: 11497535

HRT produced clear increases in spine/hip BMD and large decreases in type I collagen resorption markers—direct, strong bone-strength evidence.

PubMed ID: 11277274

IV pamidronate prevented early periprosthetic BMD loss and suppressed collagen-resorption markers—clinically relevant bone preservation.

PubMed ID: 11174476

Transdermal estradiol maintained/increased bone mass and normalized turnover markers over years — directly relevant to bone strength (HRT study).

PubMed ID: 12473698

Large RCT: rhBMP-2 delivered on a collagen sponge significantly sped tibial fracture healing and reduced reoperations; collagen acted as carrier so evidence for collagen supplement is indirect but carrier-supported bone repair is strong.

PubMed ID: 12438990

Lumbar fusion with rhBMP-2 on collagen sponge gave high fusion rates and better outcomes; again active agent is BMP-2 but collagen carrier contributed to bone healing.

PubMed ID: 12394656

Spinal fusion: rhBMP-2 on a collagen sponge increased fusion rates vs autograft; collagen was the carrier (benefit mainly from BMP-2), so moderate indirect support for collagen scaffold in bone repair.

PubMed ID: 11836043

HRT markedly lowered bone-collagen breakdown markers (NTX, dPyr), consistent with protection of bone collagen and higher bone strength.

PubMed ID: 12412806

Large RCT showed substantial increases in spine/hip BMD and reduced collagen-derived bone resorption markers (direct bone-strength evidence, though from alendronate, not collagen supplement).

PubMed ID: 12753258

COLIA1 genotype association with higher vertebral fracture prevalence supports type I collagen’s role in bone strength (genetic evidence).

PubMed ID: 12510813

IV neridronate increased spine and hip BMD and reduced fractures in osteogenesis imperfecta (a collagen disorder)—relevant to bone strength.

PubMed ID: 12859697

Large RCT: weekly ibandronate increased spine/hip BMD and strongly suppressed CTx (type I collagen resorption marker) — strong bone signal though drug intervention.

PubMed ID: 14634543

Transdermal estrogen produced substantial BMD gains and lowered collagen-resorption markers in postmenopausal women—highly relevant to bone strength.

PubMed ID: 14748475

Alendronate and etidronate reduced urinary NTx and improved symptoms in women with vertebral fractures—clinically meaningful bone benefit.

PubMed ID: 12898306

Combination therapy increased lumbar BMD and more strongly reduced urinary NTX (a collagen resorption marker)—direct relevance to bone strength.

PubMed ID: 12850861

Alendronate regimens produced substantial reductions in collagen-derived bone turnover markers and are associated with improved bone outcomes.

PubMed ID: 12874697

Pamidronate lowered total urinary collagen cross-links after hip arthroplasty, indicating reduced collagen breakdown relevant to bone remodeling post-surgery.

PubMed ID: 12830369

Large, dose-dependent suppression of serum CTx and demonstrated BMD effects with IV ibandronate—direct, strong evidence linking altered type I collagen turnover to stronger bone.

PubMed ID: 15212623

Strontium ranelate trials showed marked lumbar/hip BMD increases and stimulated osteoblast collagen synthesis in vitro—direct relevance to stronger bone.

PubMed ID: 15231011

Large alendronate trial linked reductions in collagen-related bone turnover markers to fewer fractures—supports bone-strength relationship.

PubMed ID: 14764773

Large RCT showed marked spine BMD increases and reductions in collagen turnover markers (directly relevant to bone strength).

PubMed ID: 15140336

Once-weekly alendronate markedly reduced urinary collagen crosslinks and is relevant to bone preservation.

PubMed ID: 15243278

Alendronate produced substantial spine/hip BMD gains and reduced bone collagen telopeptides (direct bone-strength evidence).

PubMed ID: 15125121

Nasal calcitonin after hip fracture reduced resorption markers, raised BMD and fewer new fractures—clinically meaningful bone benefit.

PubMed ID: 15172082

Large RCT of estradiol showed clear spine/hip BMD increases and big reductions in type I collagen breakdown—direct bone-strengthening evidence.

PubMed ID: 15478000

Five years risedronate produced substantial spine BMD gains (~+9.2%) and large reductions in collagen breakdown markers.

PubMed ID: 15205720

Long-term alendronate increased BMD—directly relevant to stronger bones (though drug, not collagen supplement).

PubMed ID: 15071723

Ibandronate substantially reduced bone turnover and vertebral fractures—strong evidence for improved bone strength.

PubMed ID: 15207885

Large 1‑yr spine BMD increase and marked reductions in bone collagen turnover markers (direct bone-strength evidence).

PubMed ID: 16257815

Alendronate strongly reduced urinary type I collagen (bone resorption) markers—direct bone/collagen metabolism effect.

PubMed ID: 15914535

Teriparatide altered bone matrix mineralization and collagen cross‑links toward a younger bone phenotype.

PubMed ID: 16133638

Milk basic protein prevented spinal bone loss and reduced a type‑I collagen resorption marker in menopausal women.

PubMed ID: 16007327

Ibandronate increased spine/hip BMD and reduced a bone resorption marker (direct bone‑strength evidence).

PubMed ID: 15840739

Early increases in bone formation/procollagen markers during teriparatide predicted later structural bone gains.

PubMed ID: 16096169

Estradiol (±nomegestrol) reduced urinary type‑I collagen peptides (bone turnover marker) in menopausal women.

PubMed ID: 16087825

Teriparatide markedly increased bone formation markers including procollagen and raised spine BMD — direct bone-strength evidence (drug trial).

PubMed ID: 16297689

rhBMP-2 on collagen sponge produced new bone adequate for implants — direct bone-regeneration outcome using collagen scaffold.

PubMed ID: 15857102

rhBMP-2 on a collagen sponge produced substantially greater bone augmentation in humans (direct bone formation evidence).

PubMed ID: 15940379

Teriparatide markedly increased histologic indices of bone formation vs alendronate in human biopsies (direct anabolic effect on bone/collagen formation).

PubMed ID: 15607868

Pamidronate reduced early femoral bone loss after hip arthroplasty and suppressed bone turnover markers (local bone‑preserving effect).

PubMed ID: 15972582

Ibandronate produced large, dose-related reductions in type I collagen breakdown markers, a strong surrogate for improved bone strength.

PubMed ID: 16133688

Alendronate increased spine/hip BMD and lowered collagen‑breakdown markers — strong bone-density data (drug trial).

PubMed ID: 16385649

Alendronate increased spine BMD substantially versus comparator, demonstrating clear bone-strength effects.

PubMed ID: 17190893

Alendronate discontinuation produced marked rises in collagen turnover markers and modest BMD losses, underscoring drug effects on bone collagen.

PubMed ID: 16684825

Teriparatide produced large rises in type I procollagen (PINP) and bone‑formation markers — mechanistic evidence linking collagen formation to bone strengthening.

PubMed ID: 16956818

Zoledronic acid substantially increased spine BMD and reduced collagen resorption markers in thalassemia patients.

PubMed ID: 16489077

Denosumab caused rapid, durable suppression of collagen‑derived bone resorption markers (NTX) — indicates preservation of bone matrix.

PubMed ID: 16449339

Early increases in a type I collagen formation marker predicted larger 1‑year spine and hip BMD gains — strong relevance to bone strength.

PubMed ID: 17159193

Zoledronic acid prevented bone loss and markedly lowered N‑telopeptide (bone collagen breakdown) and raised BMD — strong bone-strength evidence (drug, not collagen supplement).

PubMed ID: 16757759

rhBMP‑2 delivered on a collagen sponge improved fracture outcomes and reduced reinterventions/infections — strong regenerative bone benefit.

PubMed ID: 16816926

Ospemifene altered bone collagen turnover markers in a randomized trial — moderate biomarker evidence for bone effects.

PubMed ID: 16512756

Mineralized allograft (used with a collagen membrane) produced significantly greater vertical bone fill in mandibular defects — direct bone regeneration evidence.

PubMed ID: 17785705

Denosumab strongly suppressed urinary collagen telopeptide (uNTx) and reduced skeletal events — meaningful effect on bone turnover and strength surrogates.

PubMed ID: 17442659

Large RCT showed strong reductions in type I collagen resorption markers with bisphosphonates, indicating preserved bone matrix turnover (drug evidence, indirect for collagen supplementation).

PubMed ID: 17914073

Normalization of a type I collagen resorption marker on zoledronic acid associated with fewer skeletal events and lower mortality — clinically meaningful evidence linking collagen markers to bone outcomes (drug study).

PubMed ID: 17347063

Zoledronic acid produced faster/larger reductions in collagen-breakdown markers versus alendronate, supporting impact on bone collagen turnover (pharmacologic evidence).

PubMed ID: 18672985

Collagen membrane + porcine bone preserved alveolar ridge and increased mineralized bone in a human RCT (direct bone-preserving effect).

PubMed ID: 19686934

rhBMP-2 on collagen sponge produced substantial new bone formation and density vs autograft.

PubMed ID: 19571082

rhBMP-2 on collagen sponge + ceramic produced higher fusion rates and clinical improvement vs autograft.

PubMed ID: 19446148

Bisphosphonate treatment strongly suppressed a collagen breakdown marker and produced BMD gains.

PubMed ID: 19524963

Denosumab normalized elevated bone collagen resorption markers more often than continued IV bisphosphonates.

PubMed ID: 19665601

Lasofoxifene rapidly lowered bone turnover markers and increased lumbar spine BMD over 1–2 years.

PubMed ID: 19237632

Denosumab normalized urinary N-telopeptide and reduced skeletal events vs bisphosphonates — robust effect on bone resorption and clinical bone outcomes.

PubMed ID: 19339794

Aromatase inhibition in boys altered collagen bone markers and increased cortical growth (mixed safety) — evidence of bone structural change.

PubMed ID: 19858319

Randomized study: transdermal teriparatide increased spine and hip BMD and raised bone formation markers — clear anabolic bone effect.

PubMed ID: 19635616

Large RCT (BZA/CE) increased lumbar spine and hip BMD and lowered collagen-breakdown markers — strong direct evidence for bone-strengthening.

PubMed ID: 19718394

Alendronate markedly increased hip BMD and reduced collagen-resorption markers — strong bone outcome (drug study).

PubMed ID: 19816648

Bisphosphonate regimens produced large reductions in CTX (collagen telopeptide), directly linked to bone resorption control.

PubMed ID: 20031392

Large RCT: clodronate reduced PINP and increased spine/hip BMD—clear impact on bone mass (collagen-rich matrix).

PubMed ID: 20499349

Single zoledronate infusion produced large, sustained BMD gains and marked suppression of type I collagen turnover markers—direct evidence of stronger bone.

PubMed ID: 20979784

Large RCT: rhPTH markedly increased lumbar-spine BMD and bone-formation markers—direct evidence of stronger bones (drug, not supplement).

PubMed ID: 20499357

Large RCT showing substantial lumbar-spine BMD increases and reductions in collagen-derived bone resorption markers — strong direct evidence for improving bone strength (though not a collagen supplement trial).

PubMed ID: 21106710

Alendronate produced large aBMD gains and big decreases in urinary N‑telopeptide of type I collagen in children with OI — directly relevant to bone strength biomarkers.

PubMed ID: 20738314

Physiological sex-steroid regimen increased bone formation markers and produced a small but significant spine BMD gain—direct bone-strength surrogate.

PubMed ID: 21111078

Teriparatide dosing affected type I collagen markers and produced notable spine BMD gains vs constant dosing.

PubMed ID: 20458350

Alendronate increased lumbar spine BMD (~+3.5%) and reduced urinary NTX by ~57% vs comparator.

PubMed ID: 20228976

Randomized trial: collagen membrane produced substantially greater bone fill vs PLA — direct bone-strength proxy.

PubMed ID: 20814967

Large RCT: combination teriparatide+zoledronate produced clear, clinically meaningful increases in spine and hip BMD and altered collagen bone markers.

PubMed ID: 20839290

Denosumab strongly and rapidly suppressed bone collagen breakdown (CTX) and formation markers (PINP), indicating major impact on bone collagen turnover.

PubMed ID: 21442459

Large comparative trial showing faster/larger suppression of collagen turnover markers with yearly zoledronic acid vs alendronate—relevant to bone-strength biology.

PubMed ID: 21749166

Demineralized bone allograft produced substantially more new bone versus mineralized graft in socket preservation — direct bone-regeneration evidence (matrix contains collagen).

PubMed ID: 21254911

Alendronate ± raloxifene produced clear BMD increases and large reductions in urinary NTx (type I collagen degradation marker).

PubMed ID: 21796066

Zoledronic acid strongly suppressed collagen-derived bone resorption markers (urine NTx) and bone turnover vs raloxifene.

PubMed ID: 21312265

Early reductions in collagen telopeptide markers and rising spine BMD on risedronate were associated with fewer fractures.

PubMed ID: 21207053

Resistance training in older men increased bone formation vs resorption (collagen bone markers), supporting bone-strengthening mechanisms.

PubMed ID: 21963127

Growth hormone after tibial fracture raised IGF‑I and collagen‑related bone turnover markers, consistent with enhanced bone repair.

PubMed ID: 21898590

Denosumab produced large, durable suppression of collagen‑related bone turnover markers and improved BMD/fracture outcomes (strong bone effect though drug, not supplement).

PubMed ID: 21256000

Zoledronic acid sharply reduced urinary NTX (type I collagen breakdown) in bone-metastasis patients — strong evidence of reduced collagen degradation (drug effect).

PubMed ID: 21719717

Cathepsin K inhibitor produced dose‑dependent large decreases in urinary CTX (bone collagen breakdown) → indicates strong reduction in bone resorption linked to bone strength.

PubMed ID: 21240683

IV zoledronic acid produced substantially larger early reductions in serum CTX vs oral ibandronate → supports interventions that reduce collagen breakdown in bone (moderate relevance).

PubMed ID: 20740685

Three‑year randomized trial (odanacatib) produced large, sustained increases in spine and hip BMD and halved collagen resorption marker (NTx) → strong direct evidence for bone-strength effects (pharmacologic, not dietary collagen).

PubMed ID: 22791766

PTH regimens produced large increases in a type I collagen formation marker (PINP) and substantial spine BMD gains over 2 years — strong direct bone benefit.

PubMed ID: 22701017

Teriparatide produced marked increases in bone formation (PINP) vs zoledronate with biopsy-confirmed formation — direct evidence for improved bone strength.

PubMed ID: 22246217

Weight‑bearing exercise increased aBMD and reduced a collagen cross‑link marker in children—supports bone matrix improvement.

PubMed ID: 22465268

Single 5 mg zoledronate dose gave large, durable increases in spine/hip BMD and ~45–48% suppression of collagen turnover markers — direct strong bone-strength evidence.

PubMed ID: 22639400

Daily rhPTH increased lumbar spine BMD and bone‑formation markers in osteoporotic women — clear bone anabolic effect.

PubMed ID: 22776860

Eight years of denosumab produced large increases in spine/hip BMD and major suppression of CTX — strong, direct evidence of improving bone mass and collagen turnover.

PubMed ID: 22692843

Denosumab strongly suppressed bone turnover markers and altered Wnt regulators tied to bone remodeling (affects bone collagen turnover).

PubMed ID: 22971530

Bisphosphonates substantially reduced markers of type I collagen breakdown in multiple myeloma (reflects reduced bone resorption).

PubMed ID: 23135345

Teriparatide produced large, clinically meaningful increases in lumbar spine BMD over 24 months (direct bone-strengthening effect).

PubMed ID: 22348983

Lasofoxifene lowered collagen-related bone turnover markers in a large RCT (biomarker evidence consistent with reduced bone loss).

PubMed ID: 23826643

rhBMP‑2 delivered on a collagen carrier regenerated buccal bone and increased ridge width — clear localized bone formation.

PubMed ID: 23948830

Six months high‑impact exercise produced measurable increases in spine and hip BMD in postmenopausal women.

PubMed ID: 23937421

Large phase‑3 integrated trials show bazedoxifene increases spine/hip BMD and lowers fractures — direct bone-strength benefit.

PubMed ID: 24275677

Denosumab produced meaningful structural bone improvements (reduced cortical porosity, increased trabecular BV/TV) — strong bone-strength evidence.

PubMed ID: 23788684

Zoledronic acid and denosumab both lowered bone turnover markers in postmenopausal women, consistent with bone-preserving effects.

PubMed ID: 23365149

Annual zoledronic acid produced greater suppression of collagen turnover markers (β-CTx, P1NP) vs risedronate in glucocorticoid-treated patients.

PubMed ID: 24272917

Romosozumab markedly increased bone formation marker (PINP) and lumbar spine BMD — direct anabolic bone effect.

PubMed ID: 23234632

Denosumab normalized bone collagen breakdown marker (NTx) in bone metastasis patients—strong biomarker effect relevant to bone strength though in cancer context.

PubMed ID: 23425564

Everolimus+exemestane lowered bone turnover markers versus exemestane alone, indicating reduced collagen turnover in bone.

PubMed ID: 23337728

Odanacatib increased BMD and markedly lowered CTX (type I collagen resorption marker) over 2 years—robust effect on bone collagen turnover and density.

PubMed ID: 23927913

Oral risedronate markedly increased spine BMD and reduced fractures in osteogenesis imperfecta—clear bone-strength effect though drug, not supplement.

PubMed ID: 24141036

Denosumab produced rapid, large reductions in sCTX-1 and clinically meaningful BMD gains vs risedronate—strong evidence of reduced collagen resorption and stronger bone.

PubMed ID: 23771807

Nutrition intervention (iron+vit D) reduced NTx (type I collagen resorption marker) — evidence of lowered bone turnover.

PubMed ID: 23341486

Large RCT showed substantial BMD increases and changes in collagen‑derived bone markers—direct bone-strength evidence (not a collagen supplement).

PubMed ID: 23761968

Risedronate+vit D produced large ↓ in CTX (collagen resorption marker) indicating strong bone effect.

PubMed ID: 24276460

Odanacatib inhibited collagen breakdown markers (uNTx/Cr) in older adults — pharmacologic modulation of collagen turnover relevant to bone preservation.

PubMed ID: 23740422

Teriparatide trial produced large increases in PINP (type I procollagen formation marker) and vertebral strength — directly relevant to improved bone strength.

PubMed ID: 23661240

PTH treatment produced large rises in bone formation markers and BMD—strong evidence on bone-building biology (drug, not supplement).

PubMed ID: 23013236

Odanacatib produced large rapid reductions in collagen‑derived bone resorption markers (CTx/NTx), indicating direct effects on bone collagen turnover relevant to bone strength.

PubMed ID: 24066341

Collagen sponge composite graft with rhBMP‑2 produced comparable or higher viable new bone vs autograft — direct clinical evidence that a collagen scaffold supports bone formation.

PubMed ID: 24517156

Large RCT showing marked increases in spine and hip BMD with bone-active therapies (direct strong evidence for increasing bone strength, albeit drug intervention).

PubMed ID: 23775755

12-month high-impact exercise increased bone mass (femoral neck BMC), a non-pharmacologic path to stronger bone.

PubMed ID: 25425023

Zoledronate reduced urinary markers of bone collagen breakdown—indirect evidence relevant to bone preservation.

PubMed ID: 25033066

Alendronate lowered NTX and increased aBMD in fibrous dysplasia—evidence of stronger bone via antiresorptive therapy.

PubMed ID: 25027109

Oral salmon calcitonin modestly increased lumbar spine BMD and reduced CTx (collagen resorption marker) — modest bone benefit.

PubMed ID: 23761303

Zoledronate dosing increased BMD over 2 years and altered collagen‑derived bone turnover markers — relevant to bone strength.

PubMed ID: 25454689

Ibandronate IV loading produced faster reductions in collagen‑derived bone turnover markers and reduced bone pain — supports antiresorptive bone effects.

PubMed ID: 24463451

Teriparatide produced substantial BMD gains and large increases in collagen (P1NP) in OI patients—direct bone-strength evidence.

PubMed ID: 24736773

Exercise RCT showed +2.2% spine BMD and +26% P1NP — direct evidence of increased bone strength markers.

PubMed ID: 24115129

Risedronate markedly suppressed bone collagen turnover markers and slowed trabecular bone loss in postmenopausal women.

PubMed ID: 24683583

Collagen-based grafts (with high CD34+ cells) produced substantially better mandibular bone regeneration and density.

PubMed ID: 26491117

Zinc supplementation increased P1NP (procollagen type I formation marker) in girls — biomarker evidence of increased collagen/bone formation.

PubMed ID: 25607608

Denosumab produced large, clinically meaningful BMD increases and reduced type I collagen breakdown — direct strong evidence for stronger bones.

PubMed ID: 25792627

Ibandronate produced substantially larger BMD gains and much greater CTX (collagen telopeptide) reduction vs hormone therapy — strong bone benefit.

PubMed ID: 26556733

Zoledronic acid RCT produced large reductions in bone resorption and prevented new vertebral fractures (direct, high‑relevance bone strength evidence).

PubMed ID: 26466937

Risedronate pooled data showed clear, large increases in spine BMD (direct, high‑relevance to bone strength).

PubMed ID: 26499270

PEG‑IFN/ribavirin reduced CTX (bone resorption marker) substantially—biomarker evidence but therapy unrelated to supplementation.

PubMed ID: 25990355

Denosumab produced substantial suppression of bone turnover and BMD gains in treated women (direct bone‑targeting drug evidence).

PubMed ID: 25569817

Raloxifene+vitamin D increased spine/hip BMD and lowered type I collagen degradation marker (NTx) — direct effect on bone strength markers.

PubMed ID: 26043228

Liraglutide preserved bone mineral content and increased P1NP (bone formation marker) during weight maintenance (affects collagen-rich bone).

PubMed ID: 26825787

i‑Factor (synthetic collagen peptide on bone) showed noninferior/higher fusion rates — direct, strong relevance to bone repair using collagen‑based product.

PubMed ID: 27631562

Pooled RCTs showed clinically meaningful increases in spine/hip BMD and large reductions in bone collagen-degradation marker (CTX), strong evidence for improved bone strength (though not a dietary collagen trial).

PubMed ID: 27273298

Randomized clinical trial where a demineralized bovine bone graft containing 10% collagen reduced horizontal buccal bone loss vs no graft — direct collagen-containing graft bone preservation.

PubMed ID: 28025642

Exercise acutely raised bone formation/collagen-synthesis marker P1NP, supporting bone-building biology relevant to stronger bones.

PubMed ID: 28837504

Bazedoxifene RCT produced clear BMD gains and large reductions in bone turnover (collagen markers) — strongly relevant to bone strength (drug, not collagen supplement).

PubMed ID: 28687496

Romosozumab RCT produced large BMD increases and altered collagen-related bone formation markers — strong evidence collagen turnover affects bone density.

PubMed ID: 29148597

Collagenated bovine graft after extraction strongly preserved ridge dimensions and reduced bone loss — direct effect on bone preservation/healing.

PubMed ID: 28543873

Parathyroidectomy RCT showed long‑term bone density improvements and reductions in bone turnover markers (collagen‑related) — supports bone strength benefit via collagen turnover changes.

PubMed ID: 28276638

Large zoledronic acid trial produced major BMD gains and dramatic reductions in collagen type I turnover markers (PINP/CTX) — high‑quality evidence linking collagen turnover to bone strengthening.

PubMed ID: 30381400

Denosumab trial showed clear BMD increases and reductions in collagen turnover markers (direct bone outcome).

PubMed ID: 30260821

Use of collagen barrier in implant surgery produced measurable differences in peri‑implant bone levels at 3 years.

PubMed ID: 28945914

Synthetic collagen-peptide bone graft (i‑Factor) showed similar/ slightly better fusion and overall success vs autograft in cervical fusion (direct bone fusion outcome).

PubMed ID: 31050359

Use of collagen matrix with graft reduced coronal horizontal bone loss vs spontaneous healing—localized bone preservation.

PubMed ID: 30884111

Guided bone regeneration protocol using a collagen membrane produced robust horizontal width gains comparable to autogenous grafts.

PubMed ID: 30980771

Collagenated bovine bone + collagen membrane preserved sinus floor height and enabled implant placement — direct structural bone benefit.

PubMed ID: 32902105

Use of resorbable collagen membrane in ridge augmentation produced measurable horizontal bone gains at 6 months.

PubMed ID: 33217058

Collagen matrix preserved ridge width and substantially reduced need for additional augmentation — clinically meaningful bone preservation.

PubMed ID: 33084205

Collagen membrane in ridge preservation reduced horizontal/vertical bone loss vs spontaneous healing (direct bone-preservation evidence).

PubMed ID: 32315435

Surgical collagen membrane context with measured new bone formation — direct bone-regeneration relevance though not oral supplement.

PubMed ID: 31621838

Zoledronic acid markedly suppressed collagen-resorption marker (CTx) and preserved/increased spine BMD — direct bone-strength evidence (not oral collagen).

PubMed ID: 32131365

Antenatal vitamin D trial produced a ~24% greater P1NP (type I collagen formation marker) response in offspring after mechanical loading — supports increased bone collagen formation.

PubMed ID: 32626888

Bio‑Oss collagen used as comparator in dental bone repair; autologous alternative outperformed — collagen product is clinically relevant for bone fill.

PubMed ID: 33771659

Bio‑Oss Collagen sockets showed earlier ossification and tissue densification vs spontaneous healing — supports faster/better local bone formation.

PubMed ID: 34169551

Adding a collagen membrane + graft produced greater radiographic defect fill at 12 months — supports bone fill when collagen used as surgical adjunct.

PubMed ID: 33840514

Randomized trial: porcine-collagen–containing graft preserved ridge height/width vs control — direct bone-preservation benefit of a collagen-containing product.

PubMed ID: 34341833

Large RCT: zoledronic acid increased hip BMD and lowered bone-turnover markers—direct, high-quality evidence for stronger bones.

PubMed ID: 33677928

Romosozumab RCT produced large, rapid increases in spine/hip BMD and strong changes in collagen turnover markers.

PubMed ID: 33450430

Randomized exercise increased lumbar spine BMD and collagen formation marker (P1NP) — relevant to bone strength.

PubMed ID: 34324430

Zoledronic acid after parathyroidectomy increased BMD and lowered bone turnover markers vs placebo—direct BMD evidence.

PubMed ID: 33715279

Addition of enamel matrix derivative to a collagen-containing xenograft substantially increased new bone formation vs control.

PubMed ID: 36209217

Periosteum vs collagen membrane trial showed greater vertical alveolar bone gain with periosteum; indicates collagen membranes influence local bone augmentation (device context).

PubMed ID: 35938207

Ultra‑low dose estradiol reduced collagen type I turnover markers (PINP, CTX), indicating bone anti‑resorptive effects relevant to bone strength.

PubMed ID: 36216304

Calcitriol lowered CTX‑I and PINP over 48 weeks, showing suppression of type I collagen turnover tied to bone preservation.

PubMed ID: 34535967

Denosumab markedly reduced CTX/PINP and increased spine/hip BMD while on treatment — strong evidence of increased bone strength (pharmacologic, collagen markers measured).

PubMed ID: 36355053

Testosterone therapy lowered bone turnover markers and increased lumbar spine BMD over two years, consistent with stronger bone outcomes.

PubMed ID: 35977548

Phase‑3 osteoporosis drug trial showed large BMD increases — strong direct evidence for stronger bones (not a collagen supplement).

PubMed ID: 35933563

Zoledronic acid + kyphoplasty improved BMD and reduced new fractures — direct bone‑strength evidence (device/drug study).

PubMed ID: 36243220

Resistance (+ hypoxia) training reduced bone resorption markers and produced clinically meaningful regional BMD gains in older adults.

PubMed ID: 37883634

Randomized trial: 15 g collagen before brief jump sessions preserved femoral‑neck BMD vs decline in controls (site-specific bone protection).

PubMed ID: 38292488

Spa/radon treatment reduced bone resorption markers (RANKL, resorbed area) indicating bone‑protective effects relevant to bone strength.

PubMed ID: 37566071

Herbal Osteo‑F increased osteocalcin and showed COL1A1 upregulation (supports bone formation pathways).

PubMed ID: 38956196

Intermittent senolytic dosing produced short‑term increases in P1NP (bone formation marker), suggesting potential bone anabolic effect.

PubMed ID: 38866686

Small RCT in alveolar cleft grafting found improved bone healing/density when bovine collagen membrane used—direct bone healing signal.

PubMed ID: 39117478

Collagenated bovine xenograft with gingival seal preserved horizontal ridge width better than spontaneous healing—bone preservation evidence.

PubMed ID: 39064520

RCT (n=64) showed clinically meaningful clinical attachment/bone gains using a collagen membrane+graft—direct bone regeneration evidence.

PubMed ID: 38962931

Randomized trial showed collagen membrane performed non‑inferiorly for CAL/PPD and bone fill in intrabony defects—direct periodontal bone outcomes.

PubMed ID: 39228122

Guided bone regeneration trials used cross‑linked collagen barrier membranes and showed stable bone outcomes (collagen membrane present in successful bone regeneration protocols).

PubMed ID: 37522232

DBBM plus absorbable collagen membrane preserved alveolar bone height/width vs natural healing (clinical bone preservation evidence).

PubMed ID: 40386833

Collagen‑enriched bovine graft improved radiographic bone volume and clinical attachment in periodontal defects (direct bone healing benefit).

PubMed ID: 41030855

Teriparatide increased lumbar spine BMD and bone formation markers (direct bone-strengthening evidence).

PubMed ID: 40070028

Moldable bovine bone product produced a higher new bone fraction histologically at 5 months (bone formation evidence).

PubMed ID: 41353353

Direct RCT showing much higher % lamellar (mature) bone with collagen sponge + xenograft vs sponge or spontaneous healing.

PubMed ID: 40148837

Exercise + Ca/VitD raised lumbar BMD and PINP (bone collagen formation marker), supporting bone strength indirectly.

PubMed ID: 40246609

Use of collagen membrane with allograft produced greater labial bone regeneration at 1 year (direct regenerative bone outcome).

PubMed ID: 41185408

Collagen membrane enabled guided bone regeneration with substantial new bone formation at 9 months (histology).

PubMed ID: 39799466

Large randomized trial of porcine collagen membrane for periodontal regeneration produced measurable bone gain (direct biomaterial bone outcome).

PubMed ID: 40107958

GBR trial comparing porcine collagen membrane with other membranes—clinical bone outcomes broadly comparable (relevant to bone regeneration).

PubMed ID: 41184218

RCT shows covering onlay block grafts with a collagen membrane substantially increased horizontal bone gain and mature bone % (direct bone-strengthening biomaterial evidence).

PubMed ID: 41159328

Bio‑Gide (collagen membrane) used in alveolar ridge preservation with similar bone dimensional outcomes—relevant to clinical bone support.

PubMed ID: 39786610

Autogenous demineralized dentin matrix increased socket bone density at 3 months (direct bone‑density improvement).

PubMed ID: 39848799

Collagen membranes produced similar buccal bone gain in GBR for diabetic implant cases (direct bone augmentation context).

PubMed ID: 41307132

P‑15L graft produced higher 24‑month fusion rates vs autograft (radiographic fusion → stronger structural bone outcome).

PubMed ID: 25668399

Progressive impact exercise improved MRI T2 (marker of collagen integrity) in patellar cartilage (biomarker evidence for cartilage health).

PubMed ID: 15380045

Measured CTX-II and COMP and showed decreases with HRT — direct cartilage biomarker improvements.

PubMed ID: 15312255

Oral salmon calcitonin produced very large acute decreases in serum CTx and sustained marker reductions at 3 months — strong evidence of suppressed collagen resorption.

PubMed ID: 17047540

Collagen-containing compression-resistant matrix used as carrier for rhBMP-2 and improved fusion success — supports role of collagen scaffolds in connective tissue/bone repair.

PubMed ID: 17010685

Large randomized dataset: strontium ranelate reduced urinary CTX-II (type II collagen degradation) ≈15–20% — strong biomarker evidence for cartilage-protective effect (drug-based).

PubMed ID: 17482925

Bovine dermal collagen implants improved urinary incontinence outcomes—direct use of collagen as a supportive connective tissue implant.

PubMed ID: 18834243

Collagen membrane augmented periodontal defect healing—direct human evidence of collagen supporting connective tissue regeneration.

PubMed ID: 18831886

Knee OA trial observed decreased urinary type II collagen fragments (cartilage marker) along with pain reduction—directly relevant to cartilage metabolism (drug intervention).

PubMed ID: 19335074

Collagen-containing dressing promoted periodontal connective-tissue regeneration (cementum/PDL/bone) — direct evidence for supportive connective-tissue repair.

PubMed ID: 21648282

Oral hydrolyzed collagen influenced systemic bone‑remodeling biomarkers in children, supporting the concept that ingested collagen can modulate connective‑tissue biology.

PubMed ID: 21557757

Cross-linked collagen membranes produced significantly greater crestal mineralized tissue gains — strong evidence for collagen scaffold benefit.

PubMed ID: 23163915

DBBM‑C (demineralized bone with collagen) preserved ridge height/width—direct evidence that collagen‑containing grafts support local connective tissue/bone structure.

PubMed ID: 25265123

Collagen plug used in alveolar socket grafting improved bone quality and reduced residual graft particles—direct evidence for collagen as a supportive tissue scaffold.

PubMed ID: 24683578

Collagen plug ± growth factors altered early bone remodeling and residual graft material — strong relevance to collagen's role in connective tissue support.

PubMed ID: 25848134

β‑TCP–collagen matrix performed better than autograft for fusion — demonstrates collagen as a load-bearing/supportive scaffold in connective tissue repair.

PubMed ID: 33687578

Study of PRO-C2 (type II collagen formation) directly links collagen-II biology to knee OA progression—strong relevance to cartilage health.

PubMed ID: 34040361

HAP/collagen composite filler supported osteogenesis and durable structural support in vertebrae (strong biomaterial support for connective tissue repair).

PubMed ID: 32160125

Collagen/chitosan matrix dressing accelerated ulcer healing—direct application of collagen to support local connective tissue repair.

PubMed ID: 9856136

Chondroitin sulfate slowed structural progression in knee OA and improved function—directly relevant to cartilage matrix protection and collagen catabolism in cartilage.

PubMed ID: 12956481

Hydroxyapatite–collagen–chondroitin biomaterial promoted new bone-like tissue in defects—demonstrates connective tissue (bone) scaffold support.

PubMed ID: 19847319

UC‑II reduced symptoms and was associated with improved cartilage‑related outcomes vs glucosamine/chondroitin in OA patients.

PubMed ID: 26297933

Integra dermal template improved chronic wound closure—supports restoration of dermal connective tissue.

PubMed ID: 26822714

Well-powered RCT of undenatured type II collagen improved OA symptoms and reduced rescue med use—directly targets cartilage-related OA pathology.

PubMed ID: 31221944

Oral cartilage extract increased skin collagen and elasticity—systemic support for connective tissue in skin.

PubMed ID: 33213125

Oral hydrolyzed collagen II+HA+CS combo reduced synovial IL-8 and improved OA scores—biomarker and symptom support for cartilage/joint environment.

PubMed ID: 33433246

Integra+NPWT increased take rates in complex wounds—device-based improvement in connective tissue repair.

PubMed ID: 37735385

Fish cartilage hydrolysate RCT plus ex vivo serum data demonstrated preservation of type II collagen/GAG and reduced MMP‑13 — strong cartilage‑protective evidence.

PubMed ID: 40561485

Collagen supplementation as part of OA regimen produced larger symptom/function improvements, supporting cartilage health indirectly.

PubMed ID: 1829489

Collagen-impregnated vascular grafts did not increase systemic coagulation markers, relevant to safety and use of collagen materials in connective tissues.

PubMed ID: 1639582

Collagen sponge promoted ulcer healing and tissue repair—directly demonstrates a supportive role for connective tissue repair.

PubMed ID: 1639583

Bovine collagen sheets stimulated angiogenesis and tissue repair in wounds, supporting connective tissue regeneration.

PubMed ID: 8378772

Oral type II collagen improved clinical measures in RA (mechanism may involve immune modulation of anti‑collagen responses), providing moderate indirect support for cartilage-targeted effects.

PubMed ID: 8366412

Use of resorbable collagen membrane in periodontal defects produced superior hard‑tissue fill—direct evidence that collagen biomaterials support connective tissue repair.

PubMed ID: 8832475

Type I collagen membrane showed substantial improvements in periodontal defects and furcation healing—strong clinical data for collagen as supportive connective-tissue biomaterial.

PubMed ID: 9366815

Laser-induced new dermal collagen deposition demonstrates collagen's structural role in connective tissue remodeling.

PubMed ID: 9660334

Synthetic peptide+hydroxyapatite graft improved periodontal bone fill compared with other grafts — supports local connective-tissue/bone regeneration.

PubMed ID: 10781211

Living skin construct containing collagen substantially improved chronic wound healing — collagen in a construct supporting new connective tissue formation.

PubMed ID: 10629263

Collagen‑matrix skin graft accelerated ischemic wound healing and dermal repair — direct scaffold support for connective tissues.

PubMed ID: 11128913

P‑15 with ABM increased defect fill (improves extracellular matrix restoration in periodontal/bone defects; supports connective tissue repair indirectly).

PubMed ID: 11083396

Collagen hemostatic composite produced faster, more complete control of diffuse bleeding—demonstrates functional benefit of applied collagen in tissue contexts.

PubMed ID: 11052282

Collagen-fibrin patch significantly reduced time to haemostasis and blood loss—strong evidence for applied collagen supporting tissue repair/hemostasis.

PubMed ID: 10925183

Apligraf is a living, collagen-containing skin substitute that improved structural and cosmetic characteristics of grafted skin—direct connective tissue support.

PubMed ID: 11283536

Sprayable collagen-based composite produced rapid, substantially better hemostasis across surgeries—practical connective-tissue surgical aid.

PubMed ID: 11284596

Collagen composite with autologous plasma achieved faster bone-site hemostasis—strong clinical connective-tissue application.

PubMed ID: 11592359

Oral type II collagen targets type II collagen immune responses in RA—directly related to cartilage-relevant biology.

PubMed ID: 11445471

Bovine collagen injections acted as a bulking agent to restore continence—practical connective tissue support application.

PubMed ID: 11846201

CPRT (collagen membrane + collagen-containing graft) increased gingival thickness and root coverage — direct evidence that collagen products support connective tissue structure.

PubMed ID: 12428224

Prospective RA study: high urinary CTX-II (type II collagen telopeptide) strongly predicted radiologic joint damage — direct link between collagen (cartilage) degradation and cartilage health.

PubMed ID: 12356154

Collagen-based hemostatic composite achieved faster, more reliable surgical hemostasis vs collagen sponge — device-level evidence of clinically useful collagen product for tissue handling.

PubMed ID: 12874586

Long-term outcomes similar for collagen-coated vascular grafts—directly relevant to the role of collagen in implanted connective-tissue scaffolds.

PubMed ID: 14502137

Use of microfibrillar collagen hemostat reduced surgical blood loss—demonstrates functional utility of collagen biomaterials in tissue/hemostatic support.

PubMed ID: 15562912

Acellular dermal matrix improved percentage root coverage versus conventional approach—demonstrates collagen biomaterial supporting tissue.

PubMed ID: 15367197

Collagen membrane used in guided tissue regeneration produced substantial periodontal connective‑tissue and bone improvements.

PubMed ID: 15378234

Porcine dermal collagen implant (Permacol) improved urinary stress incontinence outcomes—strong evidence for collagen as supportive tissue implant.

PubMed ID: 16128596

Nimesulide significantly lowered urinary CTX‑II (type II collagen breakdown) in OA flares—direct cartilage marker effect.

PubMed ID: 16005273

Oral salmon calcitonin produced dose-dependent reductions in urinary CTX‑II (a cartilage degradation marker) — direct cartilage-relevant biomarker change.

PubMed ID: 16145678

Urinary CTX-II (type II collagen degradation) tracked with MRI bone-marrow changes in knee OA, linking collagen II turnover to cartilage status (biomarker relevance).

PubMed ID: 15855365

Randomized trial of collagen-based cartilage repair showed improved clinical and histological cartilage outcomes at 1 year (direct cartilage support).

PubMed ID: 16261778

Angio-Seal (collagen-anchor) closure device reduced complications and nursing time, demonstrating effectiveness of a collagen device supporting vascular access closure and local tissue integrity.

PubMed ID: 15966877

Bovine-derived collagen graft with a collagen membrane produced clinically important periodontal attachment gains — strong evidence for collagen-containing grafts supporting connective tissues.

PubMed ID: 15996385

Acellular dermal (collagen) matrix improved gingival root coverage and attachment—direct connective tissue support.

PubMed ID: 17181919

Polymerized type I collagen injection in RA improved joint disease metrics—supports joint/cartilage therapeutic effect in inflammatory disease.

PubMed ID: 16557055

Oral collagen hydrolysate improved wound healing (pressure ulcers) – supports connective tissue repair.

PubMed ID: 16753310

Urinary type II collagen neoepitope levels tracked and predicted knee joint‑space narrowing — biomarker linkage to cartilage status.

PubMed ID: 16936546

Collagen (bovine) used as part of an injectable implant (ArteFill) to correct wrinkles and provide structural support—direct connective tissue application.

PubMed ID: 17009253

Significant reductions in CTX‑II and other cartilage breakdown markers with salmon calcitonin — direct evidence of lowered cartilage collagen degradation.

PubMed ID: 16644224

A type I/III collagen membrane used for autologous chondrocyte implantation gave similar or somewhat better clinical results and eliminated periosteal hypertrophy — strong direct cartilage-support evidence for a collagen scaffold.

PubMed ID: 16634957

Multicenter RCT: collagen membrane with bone graft improved periodontal defect fill—supports collagen membrane as connective-tissue/attachment aid.

PubMed ID: 16757759

Collagen sponge delivery of rhBMP‑2 improved bone healing and reduced complications — demonstrates collagen scaffolds supporting tissue repair.

PubMed ID: 16512756

Collagen membrane used with bone graft improved bone fill — supports use of collagen in regenerative scaffolding.

PubMed ID: 16466166

Fuzheng Huayu reduced serum P‑III‑P (collagen III) and other fibrosis markers in responders — direct evidence of altered connective tissue collagen turnover.

PubMed ID: 17604800

Study compared collagen injection vs autologous cell therapy for sphincter support—direct clinical data on collagen injections supporting soft tissue, albeit inferior to cells.

PubMed ID: 17348883

Collagen membrane (BioGide) used for guided bone regeneration improved wound healing and implant stability — direct use of collagen material to support local connective tissue repair.

PubMed ID: 17993283

Risedronate produced dose‑dependent reductions in CTX‑II (type II collagen degradation) and lower CTX‑II at 6 months linked to less radiographic OA progression — direct biomarker evidence relevant to cartilage health (pharmacologic study).

PubMed ID: 17968918

This study measured a type II collagen neoepitope (TIINE) in OA patients—directly relevant to cartilage collagen turnover though the clinical utility was limited.

PubMed ID: 17967712

Collagen-containing dressing modulated proteases and improved diabetic foot ulcer outcomes, indicating support for extracellular matrix repair.

PubMed ID: 17580028

Collagen/ORC dressing improved wound matrix regeneration and healing—direct evidence that a collagen product supports connective tissue repair.

PubMed ID: 17162041

Porcine collagen implant used to reinforce anterior vaginal repair significantly reduced recurrence—strong evidence for connective tissue reinforcement.

PubMed ID: 18576295

Oral type II chicken collagen provided symptomatic benefit in RA (suggests chondroprotective/immunomodulatory action on cartilage).

PubMed ID: 18785308

Adalimumab produced significant reductions in urinary CTX‑II (type II collagen degradation) and MMP‑3—direct biomarker evidence of cartilage protection.

PubMed ID: 18594088

Collagen meniscus implant supported new meniscus‑like tissue formation and improved function in chronic meniscal injury—direct cartilage support.

PubMed ID: 18190562

Cross‑linked collagen membranes demonstrated lasting structural integrity in guided regeneration—direct to connective tissue scaffolding.

PubMed ID: 18254672

Collagen plug device (Angio-Seal) reduced access-site complications — demonstrates clinical utility of a collagen device for vascular access-site support.

PubMed ID: 19951408

Oral chicken type II collagen gave clinical improvements in RA (type II collagen is cartilage-specific and mediates immune tolerance).

PubMed ID: 19212858

Oral collagen hydrolysate improved knee symptoms in OA and is often interpreted as supportive of cartilage/connective tissue health though direct cartilage imaging/biopsy data are limited.

PubMed ID: 19302393

Collagen membranes supported implant defect regeneration (bone/soft tissue), demonstrating utility of collagen biomaterials for connective tissue support.

PubMed ID: 19397687

Intra-articular type I collagen improved symptoms and was associated with favorable urinary CTX-II (cartilage degradation) changes.

PubMed ID: 19189997

Apligraf (collagen-containing graft) significantly improved wound closure, reflecting connective tissue repair.

PubMed ID: 19231253

Collagen-impregnated Dacron grafts showed superior 5-year vascular patency vs ePTFE — supports the functional benefit of collagen in vascular connective-tissue applications.

PubMed ID: 19452245

High urinary CTX‑II predicted worse joint damage in RA — strong associative evidence linking cartilage collagen breakdown to outcomes.

PubMed ID: 19823853

Use of a collagen implant in wound closure accelerated healing and reduced pain — indicates a scaffold/supportive effect in tissue repair.

PubMed ID: 20039425

Tocilizumab reduced cartilage/collagen turnover biomarkers in RA (PIIANP, MMP‑3 decreases) indicating impact on cartilage matrix turnover (drug study).

PubMed ID: 20525836

In early RA, baseline collagen degradation markers (CTX‑II etc.) independently predicted radiographic progression — strong evidence that collagen markers reflect cartilage health and disease risk.

PubMed ID: 20299089

Mechanistic ex vivo data show preservation of dentin collagen via MMP inhibition—directly about collagen integrity in connective tissue matrix.

PubMed ID: 21139155

Autologous collagen‑producing tenocyte-like cell injections improved tendon structure and function—strong evidence for connective tissue repair/support.

PubMed ID: 20401752

Oral enzymatic hydrolysed collagen improved OA symptoms better than glucosamine, suggesting a positive effect on joint/cartilage-related outcomes.

PubMed ID: 20726814

Large randomized osteoporosis cohort showed significant, sustained reductions in urinary CTX‑II (cartilage type II collagen degradation marker) with treatment — direct cartilage collagen marker evidence.

PubMed ID: 20228976

Collagen membrane produced substantially greater bone fill vs PLA in periodontal regeneration — supports connective tissue/barrier function.

PubMed ID: 20926017

Collagen‑gentamicin sponge promoted better wound outcomes post‑mastectomy — local connective‑tissue healing support.

PubMed ID: 21251991

Oral collagen hydrolysate RCT (n=30) showed significant, region-specific increases in dGEMRIC T1 (proteoglycan surrogate) after 24 weeks — direct evidence of cartilage biochemical change.

PubMed ID: 21921953

Biodegradable collagen matrix implant (Ologen) provided durable surgical outcomes and distinct bleb morphology — strong evidence for a collagen scaffold supporting tissue integration.

PubMed ID: 21422390

MitraClip devices became encapsulated by type I collagen-rich fibrous tissue — observational evidence of collagen's role in device-tissue integration/ connective tissue formation.

PubMed ID: 22181689

Collagen membranes with EDTA retained doxycycline in gingival fluid for days—direct functional evidence of a collagen device supporting local tissue therapy/repair.

PubMed ID: 21701333

Avotermin led to more normal collagen organization in scars—directly relevant to improved connective tissue structure.

PubMed ID: 22282729

Collagen barrier was part of a GBR approach that improved marginal bone and aesthetics — collagen barrier contributes to peri‑implant connective tissue/bone outcomes.

PubMed ID: 22092804

Collagen‑containing graft matrix improved sinus lift and graft height, reflecting beneficial effects on connective/bone graft integration.

PubMed ID: 21679322

Exercise‑induced increases in tendon stiffness and Young's modulus demonstrate adaptive remodeling of collagen‑rich connective tissue in older adults.

PubMed ID: 22486722

Hydrolyzed cartilage supplement improved OA symptoms indicating symptomatic/supportive cartilage effects (oral cartilage extract).

PubMed ID: 22731679

Polymerized collagen injections modulated fibrosis and inflammatory markers in localized scleroderma — supportive effect on connective tissue biology.

PubMed ID: 23050490

Xenogeneic collagen matrix increased gingival thickness and keratinized tissue — local connective tissue augmentation with collagen biomaterial.

PubMed ID: 22241604

Injection of collagen-producing fibroblasts improved tendon symptoms/function in Achilles tendinosis (direct improvement in connective tissue function).

PubMed ID: 22637204

NeoCart (collagen scaffold autologous cartilage implant) produced clinically meaningful improvements in pain/function vs microfracture — strong direct evidence for cartilage repair/health.

PubMed ID: 23166425

Measured urinary CTX‑II (type II collagen degradation) and reported biomarker changes alongside symptom improvement in knee OA (cartilage-relevant biomarker signal).

PubMed ID: 24200027

Collagen nerve conduits safely supported nerve gap repair producing equivalent functional recovery — device‑level support for connective tissues.

PubMed ID: 24118844

Collagen-coated transvaginal mesh produced much higher objective anatomical cure rates—direct clinical use of collagen as structural support tissue.

PubMed ID: 23543334

Porcine dermal collagen (Strattice) used safely as an implant to support tissue repair—direct evidence for collagen scaffolds in connective tissues.

PubMed ID: 23945134

Large study showing C1M (MMP‑mediated type I collagen fragment) predicted radiographic joint progression in RA and responded to therapy — directly links collagen turnover to cartilage/joint structural health.

PubMed ID: 23512113

Collagen‑coated polypropylene mesh gave better anatomical repair in prolapse surgery — clinical benefit from collagen applied to structural/connective tissues.

PubMed ID: 24066341

Collagen sponge used as rhBMP‑2 carrier supported new viable bone formation — collagen scaffold supporting connective tissue/osseous regeneration.

PubMed ID: 23571259

Porcine collagen implant (Ologen) in trabeculectomy produced comparable success rates vs mitomycin C — demonstrates collagen implant supporting tissue remodeling and function.

PubMed ID: 24597764

Xenogeneic collagen matrix used in oral surgery produced clinically meaningful connective-tissue outcomes (root/KT results and esthetics).

PubMed ID: 24880345

Collagen hemostatic fleece used intraoperatively and performed well — direct use of a collagen material supporting tissue hemostasis/repair.

PubMed ID: 24956099

Adding a collagen matrix to periodontal surgery significantly improved root coverage—direct evidence that collagen matrix supports connective tissues.

PubMed ID: 24946965

Dermal collagen substitute improved scar elasticity and quality — demonstrable benefit to dermal connective tissue.

PubMed ID: 24947034

Topical estrogen increased type I collagen and muscularis thickness in the vagina — direct alteration of connective tissue structure.

PubMed ID: 25687834

Acellular collagen dermal matrix improved collagen organization and functional scores after burns — direct support for connective tissue repair.

PubMed ID: 26420345

Collagen‑coated transvaginal mesh produced a much higher objective anatomic cure rate vs native tissue repair — strong connective tissue support evidence.

PubMed ID: 25738178

Porcine collagen matrix acts as a connective tissue scaffold in socket preservation — supports tissue architecture.

PubMed ID: 26266436

Epithelium‑off CXL strongly prevented keratoconus progression (preserving corneal collagen structure) — robust connective tissue support in the cornea.

PubMed ID: 26233970

Vascularized periosteal membrane technique (periosteum is connective tissue) improved attachment and bone height in furcation defects (connective tissue repair technique).

PubMed ID: 25935606

Collagen meniscus implant replaced meniscal tissue and produced durable functional improvements—direct support for local cartilage/meniscal tissue health.

PubMed ID: 26419871

Use of a collagen carrier for cultured epidermal cells improved wound closure and scar quality—direct support for connective tissue function.

PubMed ID: 25959878

Collagen membrane enhanced periodontal/bone healing after extraction (direct use of collagen as supportive matrix for connective tissues).

PubMed ID: 10690882

Interventions that reduce collagen-resorption markers and increase BMD imply stronger connective tissue matrix.

PubMed ID: 26011241

Topical ORC/collagen matrix improved wound healing and modulated proteases in pressure sores (supports local connective tissue repair).

PubMed ID: 26053202

Collagen scaffold use in skin grafting directly altered dermal regeneration and fibrosis—supports connective tissue repair/regeneration.

PubMed ID: 26905565

Intra‑articular collagen product improved OA symptoms; plausible support for cartilage environment though study focused on symptoms/function.

PubMed ID: 27717210

Adding collagen matrix to periodontal surgery increased gingival thickness and keratinized width — direct evidence for connective tissue support.

PubMed ID: 28146402

Early corticosteroid injection after ACL injury significantly blunted urinary CTX‑II rise (marker of type II collagen breakdown), indicating support of cartilage biochemical environment.

PubMed ID: 27913970

LLLT in knee OA reduced urinary CTX‑II and improved cartilage‑related measures — direct evidence of reducing cartilage collagen breakdown.

PubMed ID: 27211862

16‑week aquatic resistance training changed cartilage T2 and dGEMRIC indices (markers of collagen–water environment and GAG content) in older women with mild knee OA — direct measurements of cartilage matrix changes.

PubMed ID: 27273298

DBBM with 10% collagen reduced horizontal bone loss after immediate implants — collagen‑containing graft supported peri‑implant connective/bony tissues.

PubMed ID: 28177710

Oral collagen peptides reduced activity-related knee pain in athletes; while clinical, this RCT supports a possible protective/therapeutic effect on joint tissues including cartilage (indirect).

PubMed ID: 28753100

Xenogeneic collagen matrix increased gingival thickness and improved root coverage—evidence of connective-tissue augmentation.

PubMed ID: 29087001

Collagen matrix in periodontal surgery reduced morbidity and sped recovery—practical benefit of collagen scaffold supporting connective tissues.

PubMed ID: 28548210

Xenogeneic collagen matrix thickened buccal soft tissue and reduced post‑op pain—direct effect on connective tissue augmentation.

PubMed ID: 28716215

Collagen membrane in regenerative root procedures increased dentin wall thickness and achieved clinical success—scaffold supported tissue regeneration.

PubMed ID: 28638011

Substantial reductions in skin and aponeurosis collagen I/III ratios in hernia patients indicate collagen composition is central to connective tissue integrity.

PubMed ID: 28899589

Human dermal collagen template restored thumb function comparable to tendon graft—collagen allograft supporting connective tissue reconstruction (but higher complications).

PubMed ID: 28108777

High‑quality human RCT: collagen I/III membrane + microfracture yielded superior, durable cartilage repair and MRI defect filling—strong support for cartilage scaffolding/repair.

PubMed ID: 28913600

Multicentre RCT: collagen‑hydroxyapatite scaffold produced better 2‑yr outcomes in deep osteochondral lesions — direct cartilage repair/collagen biomaterial evidence.

PubMed ID: 29157898

Collagen scaffold over rotator cuff tears increased tendon thickness and improved clinical outcomes — direct evidence collagen biomaterials support connective tissue repair.

PubMed ID: 28053158

BLCC (bovine type I collagen matrix) shifted chronic-wound gene expression toward acute healing—supports collagen matrix role in connective tissue repair.

PubMed ID: 28374714

Collagen biomaterial (Collost) markedly improved diabetic foot ulcer healing — direct evidence that collagen supports soft tissue repair.

PubMed ID: 29973970

Intramuscular collagen injections modulated muscle pain and electrical activity, indicating local connective tissue/muscle interaction and supportive effects.

PubMed ID: 30118569

Regenerative surgery for peri‑implantitis improved with collagen membrane (better PD/CAL/VDD at 12 months) showing collagen scaffold utility in soft/hard tissues.

PubMed ID: 29533674

3D collagen graft augmentation substantially reduced rotator cuff retear and improved tendon‑bone healing (strong support for connective tissues).

PubMed ID: 29564806

Conventional and accelerated corneal cross‑linking halted keratoconus progression and improved vision over 3 years by stiffening corneal collagen (direct connective-tissue effect).

PubMed ID: 28945914

Synthetic collagen‑peptide bone graft (i‑Factor) achieved high fusion rates and clinical success (collagen-based scaffold for connective-tissue/bone repair).

PubMed ID: 29565642

Collagen-membrane cell therapy (MACI) produced superior 5‑year clinical outcomes vs microfracture for cartilage defects (direct cartilage repair using collagen scaffold).

PubMed ID: 30132529

Glucosamine lowered CTX-II and C2C (type II collagen degradation markers) over 16 weeks in athletes—supports cartilage turnover modulation.

PubMed ID: 29730208

Cartilage fragment augmentation improved tendon‑bone integration and reduced tunnel widening — direct structural connective tissue benefit in ACL repair.

PubMed ID: 29497287

Eggshell membrane reduced urinary CTX-II (type II collagen degradation) and improved joint symptoms, directly supporting cartilage health.

PubMed ID: 30236087

Porcine atelocollagen implant improved objective dye-clearance and tended to better symptom relief in DCR — demonstrates functional benefit of collagen matrix in soft-tissue support.

PubMed ID: 30924600

Collagen matrix implant performed as well as mitomycin C in combined eye surgery — supports collagen as a biocompatible supportive implant.

PubMed ID: 30883942

Absorbable collagen sponge was an effective carrier for rhBMP-2 in socket preservation — functional scaffold for regenerative applications.

PubMed ID: 30927498

Novel non-cross-linked collagen membrane non-inferior for guided bone regeneration with excellent implant survival — strong evidence for scaffold/support role.

PubMed ID: 31370668

Intra-articular atelocollagen reduced knee pain vs saline, indicating symptomatic cartilage/joint benefit though structural data limited.

PubMed ID: 31785390

Multicenter RCT: porcine collagen added to microfracture significantly improved MRI cartilage defect filling and clinical pain/function outcomes (strong direct evidence).

PubMed ID: 31887743

MIV‑711 significantly lowered cartilage degeneration markers and slowed MRI cartilage thinning — direct, high‑quality evidence for cartilage structural benefit (drug intervention).

PubMed ID: 31763732

Collagen‑based hemostatic powder produced rapid hemostasis and likely provides a functional collagen matrix to support immediate connective tissue sealing.

PubMed ID: 31050359

Collagen matrix with bone graft reduced horizontal bone loss vs spontaneous healing—supports connective tissue structure preservation.

PubMed ID: 30704412

Resistance training in older adults improved tendon mechanical properties and CSA, reflecting connective tissue adaptation relevant to support/structure.

PubMed ID: 31126103

Collagen peptides + resistance training increased FFM while muscle fiber changes did not differ, suggesting connective tissue (tendon/ligament) adaptation contribution.

PubMed ID: 30980771

Collagenated graft and membrane preserved vertical bone and supported implant placement — connective tissue/bone support function.

PubMed ID: 32747306

Oxidized regenerated cellulose–collagen hemostat was non-inferior for surgical hemostasis—collagen used as surgical matrix/adjunct.

PubMed ID: 33017060

Collagen membrane used with titanium mesh produced comparable 1‑year bone and soft tissue stability—supports connective-tissue scaffolding role.

PubMed ID: 31815977

Bone graft containing 10% collagen modestly reduced soft-tissue loss at immediate implants—supports soft-tissue/connective outcomes.

PubMed ID: 32893151

Human acellular dermal matrices (collagen) influenced short-term patient satisfaction after breast reconstruction—applies to connective tissue matrix products.

PubMed ID: 32910197

Injectable collagen hydrogel scaffold used with mesenchymal stromal cells provided a structural/supportive matrix and led to modest functional cardiac improvements.

PubMed ID: 32128884

Collagen-covered grafts preserved thicker soft tissue and fewer invaginations at 8 weeks—evidence for connective tissue preservation.

PubMed ID: 32035551

Prophylactic porcine collagen mesh at stoma closure significantly reduced incisional hernia rates vs control — strong evidence that implanted collagen matrix supports connective tissue integrity.

PubMed ID: 32626888

Bio‑Oss collagen comparator used in periodontal regeneration; collagen product is an established scaffold for connective tissue repair.

PubMed ID: 33904585

Prolotherapy decreased urinary CTX‑II (type II collagen degradation) and improved symptoms in knee OA — direct cartilage biomarker improvement (interventional).

PubMed ID: 34138499

Dental collagen membrane used as biomaterial to assist regenerative outcomes — direct use of collagen to support connective tissue.

PubMed ID: 34371963

Oral hydrolyzed type II collagen improved OA symptoms — consistent with supportive effects on cartilage health/function.

PubMed ID: 34287902

Collagen matrix substitute altered root coverage outcomes and reduced postoperative pain — demonstrates connective-tissue modulation by collagen products.

PubMed ID: 34737064

Sprifermin increased cartilage thickness and altered a type II collagen formation biomarker (PRO‑C2) — direct evidence for cartilage anabolic activity.

PubMed ID: 34246825

Collagen‑thrombin hemostat product performed non‑inferiorly to standard hemostat — applied collagen product functioning as tissue support/hemostatic scaffold.

PubMed ID: 34651349

Collagen matrix increased keratinized mucosa though less than autologous graft and caused less pain — supports connective tissue augmentation with collagen product.

PubMed ID: 33817812

Xenogenic collagen matrix used for root coverage—direct use of collagen biomaterial to support connective tissue and mucogingival stability.

PubMed ID: 34598314

Use of a collagen matrix with periodontal surgery significantly increased gingival thickness — direct evidence that collagen biomaterials support connective tissue augmentation.

PubMed ID: 34359996

Direct OA cohort data linking type‑III collagen degradation marker (C3M) and CRPM to symptoms — informative about cartilage/extracellular matrix health.

PubMed ID: 34246197

αCT1 peptide changes in scar collagen organization indicate modulation of connective tissue remodeling.

PubMed ID: 35377244

Undenatured type II collagen is marketed to support cartilage immune tolerance and UC‑II improved knee ROM—direct relevance to cartilage health.

PubMed ID: 36345818

DBBM‑C (with collagen) increased mineralized tissue and reduced graft remnants over longer healing — supports connective tissue/bone regeneration.

PubMed ID: 35833539

Collagenated equine bone blocks performed similarly to autogenous bone for ridge augmentation — directly relevant to connective tissue replacement/repair.

PubMed ID: 35512781

Low‑dose UC‑II improved knee function and pain in healthy adults—supports cartilage‑related function though surrogate endpoints.

PubMed ID: 35871600

Collagen matrix + rhPDGF substantially improved root coverage and gingival thickness vs matrix alone—direct evidence collagen scaffolds support soft‑tissue/connective tissue regeneration.

PubMed ID: 35781692

Porcine collagen matrix increased buccal soft tissue thickness (though less than CTG) — direct evidence collagen products support connective tissues.

PubMed ID: 36029335

Xenogeneic collagen matrix augmented soft tissue thickness at implant sites and reduced operative time — supportive connective tissue outcome.

PubMed ID: 35324053

Porcine collagen matrix produced similar esthetic soft‑tissue outcomes to autologous grafts around implants at 1 year — collagen as a substitute to support tissues.

PubMed ID: 36364735

Oral specific collagen peptides markedly reduced periodontal inflammation and bleeding — supports connective tissue health in the periodontium.

PubMed ID: 35830145

Use of a collagen membrane in implant socket protocols produced similar ridge and esthetic outcomes—collagen membrane supports peri‑implant connective tissues.

PubMed ID: 35403756

Oral specific collagen peptide increased tendon CSA and muscle thickness — direct evidence for strengthening connective tissues (tendon).

PubMed ID: 35001559

Collagen‑rich porcine graft provided extracellular matrix that substantially improved wound repair — supports connective tissue reconstruction.

PubMed ID: 38158165

Bioinductive collagen implant substantially reduced rotator cuff retear and improved tendon structure—strong connective tissue support.

PubMed ID: 36918892

Type II chicken collagen (cartilage‑derived) reduced pain and increased lean mass/strength and is directly intended to affect cartilage/joint health.

PubMed ID: 37424319

Collagen peptides increased patellar tendon CSA during heavy training—direct evidence of connective tissue adaptation.

PubMed ID: 38071454

Volume‑stable collagen matrix provided soft tissue thickness gains around implants comparable to connective tissue grafts with less pain — supports connective tissue augmentation.

PubMed ID: 38105498

Collagen‑containing grafts/matrices reduced need for further GBR and attenuated alveolar ridge changes — strong localized connective tissue/bone support from collagen materials.

PubMed ID: 37669514

Xenogeneic collagen matrix used in gingival surgery improved esthetics and reduced morbidity vs graft alone, indicating connective tissue support.

PubMed ID: 36812821

Genipin crosslinking of sutures (collagen crosslinker) increased tendon repair strength in vitro — mechanical support to connective tissue repair (with localized cytotoxicity).

PubMed ID: 36765372

Detailed measures of aggrecan and type II collagen biomarkers (huARGS, C2M, PRO‑C2) show exercise intensity alters cartilage remodeling — directly relevant to cartilage collagen biology.

PubMed ID: 37846853

Augmentation with collagenated xenograft produced similar implant/patient outcomes to autogenous bone — collagen scaffold supports connective tissue/bone architecture.

PubMed ID: 38829812

Undenatured type II chicken collagen improved knee OA symptoms, consistent with immune-modulatory cartilage support.

PubMed ID: 38235711

High-functional bovine collagen peptide trial reduced CTX-II (cartilage degradation marker) by ~22–34% and improved clinical outcomes—strong cartilage support.

PubMed ID: 38928934

Specific collagen peptides reduced joint pain and improved function—clinical signals consistent with cartilage support.

PubMed ID: 38551128

Atelocollagen patch augmentation reduced rotator cuff retears — supports connective tissue repair/strength.

PubMed ID: 38485651

Connective tissue grafts vs collagen matrix trials show collagen matrices support peri‑implant soft tissue, though autologous grafts performed better long‑term.

PubMed ID: 39660548

Five‑year data show free gingival grafts outperform collagen matrix for keratinized mucosa, but collagen matrix still provided connective tissue support with less morbidity.

PubMed ID: 38562624

Collagen meniscal scaffold led to measurable meniscal volume regeneration and defect filling vs meniscectomy — direct support for meniscal/cartilage structural restoration.

PubMed ID: 38734130

Bioinductive collagen implant produced organized tendon collagen and thicker healed tendon — direct and strong evidence for improving connective tissue structure.

PubMed ID: 38748295

Allogenic collagen scaffold at implant sites produced measurable peri‑implant soft‑tissue thickening and incorporation—direct connective tissue support from collagen biomaterial.

PubMed ID: 39536202

Xenogeneic collagen matrix supported root coverage and keratinized tissue width—evidence that collagen matrices support soft connective tissues.

PubMed ID: 39755603

Oral collagen‑containing product improved outcomes in meniscopathy (involving cartilage/meniscal tissues), suggesting some cartilage support though product was multi‑ingredient.

PubMed ID: 39953742

Collagen membrane over PTFE mesh altered pseudo‑periosteum volume and some bone outcomes—supports local soft tissue/bone interface regeneration.

PubMed ID: 40237733

Undenatured type II collagen product (Artneo) improved OA pain/function—suggestive of cartilage immunomodulatory/supportive effects.

PubMed ID: 40462003

Porcine collagen matrix achieved high root coverage—clinical connective tissue reconstruction result.

PubMed ID: 40209829

Bovine bioinductive collagen implant reduced rotator cuff retear rate—supports structural repair of connective tissue.

PubMed ID: 40199770

Collagen matrix restored papillary structures with less pain—collagen biomaterial supporting soft connective tissues.

PubMed ID: 40254798

Collagen matrix produced measurable soft tissue thickness gain around implants with less early pain—direct evidence collagen product supports connective tissue augmentation.

PubMed ID: 40386833

Adding collagen‑enriched bovine graft improved clinical attachment, probing reduction and bone fill—supports ECM/connective tissue regeneration.

PubMed ID: 40105088

Collagen matrix increased peri‑implant soft tissue volume with less early morbidity though somewhat greater mid‑term shrinkage—supports connective tissue use.

PubMed ID: 40009192

Collagen membrane in gingival recession produced similar root coverage to CTG with less donor morbidity—collagen membrane supports connective tissue repair.

PubMed ID: 40542468

Xenogeneic collagen matrix used effectively for soft-tissue augmentation around implants (direct connective tissue application).

PubMed ID: 39876067

Autologous dermal fibroblast injection at tendon interface markedly reduced retear rate—strong evidence of improved connective tissue repair.

PubMed ID: 40298001

Collagen membrane group had fewer infections and effective alveolar width gain in lateral ridge augmentation (favourable clinical profile for collagen membranes).

PubMed ID: 40126197

Collagenated block material provided greater immediate crestal thickness (collagenated biomaterial supporting tissue volume).

PubMed ID: 39843351

Collagen matrix + rhPDGF improved early graft perfusion and predicted better root coverage and tissue volume gains (connective tissue regeneration).

PubMed ID: 41353353

Collagen sponge used in socket preservation increased lamellar bone formation when combined with xenograft (supporting local connective tissue matrix formation).

PubMed ID: 40246609

Collagen membrane with allograft enhanced labial bone regeneration — supports peri‑implant connective tissue/bone interface.

PubMed ID: 40874422

Collagen sponge dressing accelerated wound healing and reduced pain after palatal graft harvest (connective tissue repair).

PubMed ID: 41354715

Medical collagen plus laser reduced inflammation and accelerated mucosal healing, supporting local connective tissue regeneration.

PubMed ID: 39955202

Collagen membrane comparator trial showing effective soft-tissue healing — supports connective tissue regeneration capability.

PubMed ID: 41185408

Collagen membrane supported horizontal bone augmentation with substantial new bone content — evidence for structural connective tissue support.

PubMed ID: 39799466

Collagen membrane used for periodontal regeneration improved clinical attachment and soft tissue outcomes (relevant to connective tissue support).

PubMed ID: 40838330

Crosslinked collagen matrix added to coronally advanced flap produced significantly greater gingival thickness gain at 6 months (direct soft‑tissue volume support).

PubMed ID: 40984016

Volume‑stable collagen matrix increased peri‑implant mucosal thickness and reduced morbidity vs autograft — direct connective tissue support evidence.

PubMed ID: 41495722

Collagen matrix (xenogeneic) performed comparably to connective tissue graft for gingival augmentation—direct evidence collagen biomaterial supports connective tissue repair.

PubMed ID: 11074998

Graftskin supplies a collagen‑rich dermal matrix, improving dermal repair and providing direct evidence that collagen matrices support connective tissue restoration.

PubMed ID: 24580752

Improved collagen maturation and biomechanical strength at tendon‑to‑bone repairs (animal) indicates support for connective tissue integrity.

PubMed ID: 28549430

IA hyaluronic acid reduced Coll2‑1, a serum marker of type II collagen degradation, indicating direct impact on cartilage collagen turnover.

PubMed ID: 28056936

CS‑OSA reduced urinary CTX‑II (type II collagen breakdown) and serum COMP in men—direct biomarker evidence for cartilage protection.

PubMed ID: 39906986

Irbesartan reduced arterial events in vascular Ehlers‑Danlos (a primary collagen disorder)—strong clinical evidence affecting connective tissue outcomes.

PubMed ID: 12192323

The amino-acid mix enhanced wound collagen deposition, indicating support for connective-tissue collagen synthesis.

PubMed ID: 33143647

Randomized trial adding atelocollagen to microfracture significantly improved MRI MOCART cartilage‑repair scores vs microfracture alone — direct evidence that collagen scaffold supports cartilage repair quality.

PubMed ID: 39203831

Collagen-containing multi-nutrient supplement produced robust increase in intervertebral disc volume (structural cartilage-related effect).

PubMed ID: 38785054

Product containing undenatured type II collagen reduced synovitis on MRI and improved stiffness—supports cartilage/joint tissue benefit (multi‑ingredient).

PubMed ID: 39875757

Nutraceutical lowered serum CTX‑II (type II collagen degradation) and increased PIIANP (synthesis) with large WOMAC improvements—strong biomarker and clinical signal for cartilage support (product, not collagen).

PubMed ID: 9111393

Use of bovine-collagen composite graft for fracture repair directly demonstrates collagen's role in structural/connective tissue reconstruction.

PubMed ID: 9522323

HRT decreased collagen formation/resorption markers (PICP, ICTP), demonstrating modulation of connective tissue collagen turnover.

PubMed ID: 9209198

Urinary NTx tracked collagen telopeptide turnover that relates to connective tissue (bone) remodeling — useful biomarker for collagen status.

PubMed ID: 30039526

Vitamin C adjunct improved soft-tissue healing scores when collagen-containing grafts were used in dental implant surgery (clinical wound-healing benefit).

PubMed ID: 34246197

αCT1 peptide treatment altered wound collagen organization toward normal and had clinical/biopsy evidence — supportive for improved healing/scar outcomes.

PubMed ID: 34468410

Microneedling and fractional CO2 laser increased collagen content and improved scars — procedural promotion of skin remodeling and healing.

PubMed ID: 34837931

Mucosamin spray (hyaluronate + amino acids) significantly reduced radiation oral mucositis severity and shortened symptom duration — clear mucosal/wound healing benefit.

PubMed ID: 36516090

Topical COL7A1 gene therapy produced large, clinically meaningful increases in complete wound healing in dystrophic EB — direct and strong effect on skin healing.

PubMed ID: 35742357

Topical fish collagen gel around venous leg ulcers improved healing rates, pain and QoL vs placebo—direct evidence that collagen (topical) speeds skin wound healing.

PubMed ID: 35839158

Bovine collagen dressing matched amniotic membrane for healing time and scar outcomes in pediatric burns — supports collagen dressings for wound healing.

PubMed ID: 35080127

Bioactive split‑thickness skin allograft (native collagen) markedly increased diabetic foot ulcer healing rates and speed vs standard care (strong, direct evidence for collagen-containing biomaterials and wound healing).

PubMed ID: 35001559

Porcine ECM (collagen‑containing) bilayer graft markedly improved diabetic foot ulcer healing rates and time to heal versus standard dressing.

PubMed ID: 38962824

Xenogeneic collagen matrix produced scar outcomes comparable to skin grafts for small head/neck defects — supports effective healing/scar outcomes.

PubMed ID: 36724726

Randomized burn trial: oral collagen hydrolysate (40 g/day) significantly shortened time to 95% and complete wound healing and improved scar scores vs placebo.

PubMed ID: 38181297

Medical collagen sponge modestly shortened healing time in infant burns (best results when combined with rhGM-CSF)—direct wound-healing application of collagen.

PubMed ID: 39627329

Nanofat ± PRP injections increased type I collagen and produced clinical improvement in striae tissue after abdominoplasty — evidence of enhanced dermal remodeling/healing.

PubMed ID: 39630663

ReFORM & RePAIR improved collagen deposition and barrier restoration — supports faster functional skin repair.

PubMed ID: 39536202

Xenogeneic collagen matrix improved root coverage and keratinized tissue width (18 mo) though slightly less gingival thickening vs CTG—supports soft‑tissue healing/coverage with collagen biomaterial.

PubMed ID: 37522232

DBBM + collagen membrane socket preservation preserved alveolar dimensions vs natural healing (improved post‑extraction healing outcomes).

PubMed ID: 40199770

Collagen matrix rebuilt interdental papillae as effectively as CTG with less pain—direct evidence for collagen scaffold aiding soft tissue healing.

PubMed ID: 40316795

Collagen sponge in tooth sockets reduced early post‑op pain—supports local collagen aiding oral wound healing.

PubMed ID: 40254798

Collagen matrix produced comparable soft tissue thickness gains around implants with less early pain vs connective tissue graft—supports faster/less morbid soft tissue recovery.

PubMed ID: 39843351

Collagen matrix soaked with rhPDGF increased early graft perfusion and predicted superior 6-month root coverage (accelerated healing marker).

PubMed ID: 40069407

Fractional CO2 improved scar appearance and increased collagen/elastin deposition consistent with remodeling/healing.

PubMed ID: 40874422

Randomized trial: collagen sponge dressings after palatal graft harvest sped early epithelialisation and reduced early postoperative pain vs gelatin sponges.

PubMed ID: 41354715

Medical collagen adjunct + lasers after extraction reduced pain, swelling and local inflammation and accelerated mucosal/socket healing.

PubMed ID: 39955202

Gelatin/PCL membrane performed as well as collagen membrane for oral soft-tissue healing at one month — evidence for effective mucosal repair.

PubMed ID: 39933410

Herbal ointment improved wound closure and histologic angiogenesis/epithelialization (direct wound‑healing outcomes).

PubMed ID: 41394293

Arrabidaea chica gel healed oral mucositis substantially faster than low‑level laser (direct mucosal healing outcome).

PubMed ID: 40633745

CO2 laser + photodynamic therapy increased healing rate and measured collagen content in chronic infected wounds (direct wound‑healing collagen outcome).

PubMed ID: 9582466

Injectable 5‑FU/adrenaline in a collagen gel vehicle produced higher and faster wart clearance — collagen vehicle improved local healing outcomes.

PubMed ID: 9006374

Fluorouracil/epinephrine with bovine collagen gellant was notably more effective for external lesions — demonstrates collagen gellant aiding local lesion resolution.

PubMed ID: 11074998

Bioengineered bilayer skin (collagen‑rich dermal matrix) markedly improved venous ulcer healing rates and time to closure — direct evidence for faster skin healing.

PubMed ID: 30048322

Oxandrolone+propranolol reduced scar severity and improved scar histology after burns—clear evidence of improved wound/scar healing outcomes.

PubMed ID: 34214683

Randomized clinical data: anthocyanin niosome gel accelerated oral wound closure and increased collagen expression — direct wound‑healing evidence (topical, not oral collagen).

PubMed ID: 2382229

Oral arginine increased new collagen (hydroxyproline) in standardized subcutaneous wounds—direct evidence for faster/greater wound collagen deposition.

PubMed ID: 8342121

In elderly volunteers oral arginine increased wound hydroxyproline and total protein in wounds—strong evidence of enhanced wound collagen deposition.

PubMed ID: 12192323

Direct measurement: specialized amino-acid supplement produced a significant increase in wound hydroxyproline (collagen) vs control—strong indication for faster/greater collagen deposition in healing.

PubMed ID: 18834243

Use of a collagen membrane improved periodontal defect healing compared with surgery alone—direct clinical evidence that collagen biomaterials accelerate local tissue repair.

PubMed ID: 19335074

Direct clinical study: collagen-containing wound dressing with growth factor produced histologic periodontal regeneration and clinical improvement — strong direct evidence for local tissue healing.

PubMed ID: 22011820

Randomized trial: a bovine collagen‑calcium alginate dressing significantly sped epithelialization and reduced donor‑site pain — high‑quality direct evidence for faster skin healing.

PubMed ID: 25265123

Use of a collagen plug in grafted sockets improved observed bone quality and early healing parameters — relevant to tissue healing where collagen matrix used.

PubMed ID: 24683578

Sockets grafted with growth factors and collagen plug showed fewer residual graft particles and altered early healing at 8 weeks — supports faster local healing with collagen biomaterials.

PubMed ID: 32160125

RCT of a collagen/chitosan matrix dressing in diabetic foot ulcers showed faster and higher rates of complete healing—strong direct evidence for collagen in promoting wound healing.

PubMed ID: 26297933

Large RCT: Integra dermal template increased diabetic foot ulcer healing rates and shortened time to closure vs standard care—robust wound-healing evidence for a collagen-containing device.

PubMed ID: 33433246

Combining Integra with NPWT increased graft take and shortened hospitalization in complex wounds—device-based acceleration of skin healing.

PubMed ID: 1639582

Direct clinical trial: heterologous collagen sponge applied to skin ulcers markedly accelerated healing and improved closure rates (strong direct evidence).

PubMed ID: 1639583

Topical bovine collagen sheets on open wounds accelerated healing, increased blood flow and stimulated tissue repair (strong direct evidence).

PubMed ID: 1395879

Randomized trial: gentamicin–collagen sponge dramatically reduced postoperative abscess formation, indicating improved local wound outcomes and healing.

PubMed ID: 7673302

Collagenase ointment significantly shortened time to clean wound bed and to healing in partial‑thickness burns — strong direct clinical evidence for faster wound healing.

PubMed ID: 8667576

Collagen combined with platelet-derived growth factors accelerated wound epithelialization: 69% healed by 6 weeks and all by 10 weeks—strong direct evidence for faster healing.

PubMed ID: 8832475

Type I bovine collagen membrane produced meaningful improvements in periodontal/bone defect healing—strong biomaterial evidence for enhanced local tissue repair.

PubMed ID: 8606715

Maintaining normothermia during surgery increased wound collagen deposition and reduced infections/length of stay — direct evidence that conditions affecting collagen deposition influence healing speed.

PubMed ID: 9040266

Use of a collagen plug after arterial puncture shortened bleeding time and reduced pain vs manual compression — direct procedural wound-healing advantage (hemostasis) from collagen device.

PubMed ID: 9729942

Collagen–alginate dressing significantly improved wound-size reduction and complete healing rates vs saline-gauze in diabetic foot ulcers — strong direct evidence.

PubMed ID: 9521027

Cultured human skin equivalent accelerated venous ulcer healing and halved median time to closure vs compression alone — robust clinical regenerative effect (contains collagen matrix).

PubMed ID: 9880419

Collagen‑gentamicin implant significantly reduced surgical wound infections and shortened healing time in contaminated abdominal wounds.

PubMed ID: 10781211

Randomized trial: living skin construct containing collagen (APLIGRAF) healed chronic venous leg ulcers faster and more completely than compression alone — direct, high‑quality evidence for accelerated skin wound healing from a collagen‑containing product.

PubMed ID: 10514397

Topical estrogen sped wound healing in older adults and was associated with increased collagen in wounds — directly relevant to faster healing.

PubMed ID: 11030881

Sprayable collagen-thrombin-plasma composite arrested liver bleeding faster than standard sponge in surgical patients — strong device-level evidence of collagen aiding hemostasis/wound control.

PubMed ID: 10629263

Type I bovine collagen-matrix skin graft markedly accelerated ischemic foot wound healing vs standard dressings (direct, large effect on wound closure rates/times).

PubMed ID: 11083396

Collagen-based hemostatic composite produced much faster and more complete control of diffuse bleeding—supports faster surgical wound stabilization.

PubMed ID: 11052282

Collagen patch coated with fibrin components significantly reduced time to haemostasis and intraoperative blood loss—directly accelerates surgical wound control and early healing.

PubMed ID: 10925183

Apligraf applied over meshed autografts improved pigmentation, vascularity, scar appearance and pliability—strong wound-healing benefit from a collagen-containing skin analog.

PubMed ID: 11801985

Placement of acellular dermis (collagen-rich) altered post-surgical outcomes and wound-related complications while markedly reducing a complication (Frey's) — device evidence of altered healing dynamics.

PubMed ID: 11213881

Graftskin (living skin equivalent) increased 12-week healing rates and sped closure in diabetic foot ulcers — strong clinical evidence for faster healing.

PubMed ID: 11754859

Gentamicin-impregnated collagen fleeces markedly reduced postoperative perineal/sacral infections and improved local outcomes — supports faster/safer wound healing when used as a collagen carrier.

PubMed ID: 11266253

Gentamicin-laced collagen tampons in hernia repair significantly lowered wound infection rates — strong clinical evidence that collagen dressings can improve surgical wound outcomes.

PubMed ID: 12093340

Large RCT: collagen/oxidized cellulose dressing (Promogran) increased healing rates of diabetic foot ulcers overall and showed borderline significance for recent ulcers (direct wound-healing benefit).

PubMed ID: 12430368

Promogran (collagen dressing) significantly reduced wound surface area vs control and trended to more healed ulcers (direct wound-healing data).

PubMed ID: 12558709

Randomized trial: topical collagen dressings healed pressure ulcers at similar rates to hydrocolloid; direct clinical evidence that collagen dressings can support wound healing.

PubMed ID: 12780882

Adding a gentamicin-collagen fleece to primary closure greatly shortened healing time after pilonidal surgery—strong clinical wound-healing benefit.

PubMed ID: 15375668

Gentamycin-collagen sponge after rectal cancer surgery reduced early complications and improved outcomes—supports enhanced surgical healing.

PubMed ID: 15867662

Collagen hemostatic gel (Floseal) provided better hemostasis, less pain and fewer rebleeds vs packing—direct wound/hemostasis benefit.

PubMed ID: 15620935

Large RCT: collagen‑gentamicin sponge roughly halved sternal wound infections—strong evidence for improved surgical wound outcomes/healing.

PubMed ID: 16383040

Dermlin topical increased type IV collagen expression and accelerated wound closure including diabetic foot ulcers (direct wound‑healing evidence).

PubMed ID: 15966877

Bovine‑derived collagen graft plus membrane produced larger pocket reductions and attachment gains in periodontal surgery versus surgery alone — strong clinical evidence for improved periodontal tissue healing using collagen graft materials.

PubMed ID: 15996385

Acellular dermal collagen matrix graft produced improved root coverage and gingival healing at 1 year—direct healing benefit from collagen matrix.

PubMed ID: 16557055

Oral concentrated collagen hydrolysate modestly improved pressure‑ulcer healing scores over 8 weeks vs placebo in a randomized trial.

PubMed ID: 16679905

Collagen foil dressing produced similar healing times to other dressings for donor site wounds — direct evidence for collagen dressing supporting wound healing (moderate).

PubMed ID: 16612303

Cultured skin substitutes on collagen sponges reduced donor-harvest needs and achieved good engraftment — strong wound-healing evidence using collagen scaffold.

PubMed ID: 18458383

Topical rbFGF on an absorbable collagen sponge markedly increased and accelerated complete healing of chronic ulcers (high-quality direct wound-healing effect).

PubMed ID: 17348883

Use of a collagen membrane in implant socket grafting led to good wound healing/flap closure rates and implant stability — supports enhanced local soft-tissue healing with collagen membrane use.

PubMed ID: 17931240

Large RCT (n=2000) showed gentamicin-loaded collagen sponges halved sternal wound infection rates—strong evidence of improved surgical wound outcomes.

PubMed ID: 17967712

A protease-modulating collagen-containing dressing combined with platelet factors significantly improved diabetic foot ulcer size reduction vs either alone — strong wound-healing benefit.

PubMed ID: 17580028

Randomized controlled trial where a collagen‑based protease‑modulating dressing markedly increased healing rates and shortened time to healing for diabetic foot ulcers—strong direct evidence for faster skin/wound healing.

PubMed ID: 18728597

Collagen matrix used during cranial procedures markedly reduced CSF effusion and operative complications—improved surgical healing outcomes.

PubMed ID: 18692646

Use of collagen/fibrin patch with electrocautery substantially reduced postoperative air leaks and shortened leak duration—practical healing benefit.

PubMed ID: 18190562

Cross‑linked collagen membranes persisted longer and supported guided bone/tissue regeneration—relevance to wound/matrix healing.

PubMed ID: 18533208

Guided‑tissue regeneration with bovine bone + collagen membrane improved healing of transosseous periapical defects—collagen membrane aided tissue repair.

PubMed ID: 18605602

Adding bone graft + resorbable bovine collagen membrane to endodontic surgery improved healing rates (88% vs 57%) — direct evidence that collagen-based membrane enhances tissue healing in surgical context.

PubMed ID: 19189997

Apligraf (collagen-containing skin substitute) doubled 12-week complete healing rates of diabetic foot ulcers vs standard care.

PubMed ID: 19776082

Collagen/fibrin patch at lobectomy reduced air-leaks and hospital stay — demonstrates surgical wound/healing benefit from collagen patch.

PubMed ID: 19823853

Randomized trial found primary closure over a gentamicin‑collagen implant sped healing and reduced pain vs leaving wound open — direct, high-quality evidence for faster healing using a collagen product.

PubMed ID: 20676860

Topical bovine type I collagen spray produced 100% complete healing of anal fissures in treated children at 4 weeks—strong direct wound‑healing evidence.

PubMed ID: 20536470

Topical thymosin β4 (affects collagen deposition) appeared to speed healing in some venous ulcers (~25% healed in 3 months) — moderate supportive evidence (not a collagen supplement).

PubMed ID: 20492632

Autologous lipoaspirate cell grafts markedly increased fibroblast collagen synthesis in vitro and produced substantially higher/faster diabetic foot ulcer healing rates.

PubMed ID: 20819439

Gentamicin-containing collagen sponge in pilonidal wounds significantly shortened healing time and reduced infections/recurrences vs oral antibiotics.

PubMed ID: 20926017

Randomized trial: local collagen‑gentamicin sponge after mastectomy significantly reduced infections, seromas and drainage — clear clinical improvement in surgical wound healing.

PubMed ID: 21614910

Applying type I collagen powder in axilla after mastectomy reduced lymph drainage and duration in patients with many nodes removed — clinically meaningful local healing benefit.

PubMed ID: 21885068

Retrosternal gentamicin–collagen sponge significantly reduced deep sternal wound infections and improved wound outcomes (collagen sponge promoted local healing).

PubMed ID: 21921953

Collagen implant (Ologen) provided similar long-term IOP control and produced characteristic bleb morphology without adverse reactions — indicates good wound modulation/healing in glaucoma surgery.

PubMed ID: 21701333

Avotermin improved scar appearance and normalized collagen organization after surgical revision—evidence of improved remodeling/healing quality.

PubMed ID: 21269351

Microneedling induces controlled dermal injury and collagen remodeling that accelerates scar remodelling and local repair.

PubMed ID: 21741471

A relaxation intervention before surgery increased hydroxyproline deposition (collagen) in wounds, indicating faster/greater collagen deposition and healing.

PubMed ID: 21371164

Randomized trial in diabetic foot ulcers: formulated bovine collagen gel produced faster early wound‑healing rates vs standard care (clinically meaningful effect).

PubMed ID: 22659765

Topical gentamicin‑collagen sponge increased cure rates and sped pathogen eradication in diabetic foot infections — improved wound healing outcomes.

PubMed ID: 22703794

Topical collagenase vs silver sulfadiazine in partial‑thickness pediatric burns — collagenase used for debridement and healing; similar outcomes (direct wound‑healing relevance).

PubMed ID: 22691828

A collagen‑based fibrin sealant (TachoSil) applied to staple line reduced bleeding and limited Hb/RBC drops after sleeve gastrectomy, reflecting improved surgical hemostasis/wound sealing (faster clinical healing support).

PubMed ID: 23438054

Randomized trial: collagen/ORC/silver dressing markedly increased early healing rates and reduced infection withdrawals in diabetic foot ulcers — strong evidence for faster wound healing.

PubMed ID: 24993838

Gentamicin collagen sponge reduced organ‑space infections after rectal cancer surgery (in patients without leak) — supports better surgical outcomes and healing.

PubMed ID: 24946965

Allogeneic dermal collagen substitute used with grafting improved long‑term scar elasticity and graft take — strong surgical wound healing benefit.

PubMed ID: 25424146

Randomized trial: collagen‑rich amnion/chorion graft (EpiFix) greatly accelerated and increased healing rates of diabetic foot ulcers vs comparators.

PubMed ID: 25006854

PRP, TCA and needling improved scar appearance and are used to stimulate remodeling/healing of dermal defects.

PubMed ID: 25687834

Acellular collagen dermal matrix plus grafts improved histologic and functional healing after severe burns vs graft alone — strong healing evidence.

PubMed ID: 26551647

Collagen dressing plus compression markedly increased granulation tissue and ulcer area reduction vs control in hard-to-heal venous leg ulcers (strong wound-healing benefit).

PubMed ID: 26419871

Cultured epidermal cells in a collagen carrier improved early epithelialization and long-term scar outcomes in burn patients (direct, robust wound healing effect).

PubMed ID: 25959878

Resorbable collagen membrane after tooth extraction improved probing depths and bone fill at 6 months (accelerated periodontal healing locally).

PubMed ID: 26011241

ORC/collagen matrix dressings significantly sped pressure‑sore healing vs foam and reduced protease activity (direct wound‑healing collagen matrix evidence).

PubMed ID: 26053202

Collagen-containing scaffolds influenced regenerated dermis thickness and fibrosis in acute wounds—evidence for improved healing/regeneration.

PubMed ID: 26147455

PRP increased collagen in skin and improved striae clinically—evidence that increased dermal collagen improves skin repair and appearance.

PubMed ID: 29298017

Randomized trial: local collagen dressings significantly reduced diabetic foot ulcer area and depth vs standard care — strong clinical evidence for collagen dressings accelerating wound healing.

PubMed ID: 28914681

RCT: collagen/ORC/silver dressing trended to faster venous leg ulcer healing vs standard care—direct wound-healing evidence.

PubMed ID: 28544150

Acellular dermal matrix (collagen-rich) healed diabetic foot ulcers faster and maintained closure better than standard care — strong wound-healing effect for a collagen product.

PubMed ID: 29675430

Randomized trial in diabetic foot ulcers: pirfenidone markedly increased COL1α expression (~50–69×) and produced rapid wound closure—strong evidence of accelerated collagen‑mediated healing (though not a collagen supplement).

PubMed ID: 28119114

PRP gel dramatically sped healing and increased histologic collagen deposition after pilonidal sinus surgery — large, randomized clinical benefit for wound healing.

PubMed ID: 28053158

Randomized human study: collagen-based living skin construct reprogrammed chronic leg ulcers toward an acute-healing gene signature (strong evidence for faster wound healing).

PubMed ID: 28264130

Matrix-regenerating RGTA eye drops dramatically accelerated corneal epithelial healing vs standard care (direct ECM/collagen-targeted healing).

PubMed ID: 28374714

Multicenter RCT: adding Collost (collagen biomaterial) to standard therapy markedly increased healing rates and sped complete epithelialization in diabetic foot ulcers — direct, strong evidence for accelerated healing.

PubMed ID: 30061579

Randomized DB human trial: oral collagen hydrolysate (CH‑b) significantly improved pressure‑ulcer healing (PUSH/PSST/wound area).

PubMed ID: 29713890

Applying cyanoacrylate over a collagen sponge on palate wounds reduced postoperative pain and analgesic use and improved early healing comfort (improves wound recovery experience).

PubMed ID: 29953106

Topical collagen biomaterial (Collost) markedly accelerated diabetic foot ulcer size reduction and increased healing rates vs standard care in an RCT.

PubMed ID: 29921408

Hyaluronate plus collagen-precursor amino-acid spray reduced duration and severity of oral mucositis—promotes mucosal healing.

PubMed ID: 31536746

Topical porcine type I collagen dressings doubled complete healing rates and halved time to 50% ulcer reduction in diabetic foot ulcers—strong, direct evidence for faster skin wound healing.

PubMed ID: 31878810

Topical recombinant EGF increased collagen deposition and substantially improved diabetic foot ulcer healing rates and times vs placebo.

PubMed ID: 31859087

Oral hydrolyzed collagen markedly accelerated burn wound healing (HR 3.7) and improved serum pre‑albumin — strong direct evidence for faster healing.

PubMed ID: 30845084

Bone marrow aspirate delivered in a collagen sponge accelerated early bone/wound regeneration and reduced pain vs hydroxyapatite alone—direct wound-healing acceleration where collagen sponge was a component.

PubMed ID: 31903299

Topical fibrillar collagen wound matrix significantly accelerated diabetic foot ulcer healing (earlier area reduction, higher closure incidence).

PubMed ID: 32183831

Absorbable collagen sponge in extraction sockets reduced early postoperative pain and improved short‑term periodontal healing (clinical benefit).

PubMed ID: 32094049

Gentamicin-collagen sponge implants markedly reduced surgical-site infections in high‑risk centers — improves wound-related outcomes and likely accelerates effective healing in those settings.

PubMed ID: 32131656

Randomized trial of a collagen-laminin dermal matrix with resveratrol microparticles roughly doubled 4-week wound closure rate — strong direct effect on skin healing.

PubMed ID: 32710584

Acellular porcine dermis and polynucleotide‑HA dressings significantly accelerated re‑epithelialization and increased collagen I deposition and cellular healing markers vs standard foam in chronic ulcers.

PubMed ID: 32662209

Boric acid–impregnated sponges with NPWT increased collagen synthesis and fibroblast counts versus silver sponges — accelerated wound healing biomarkers (topical product).

PubMed ID: 34039476

Acellular collagen graft (Alloderm) substantially reduced fistula recurrence after hypospadias repair — demonstrates improved surgical tissue healing with collagen graft.

PubMed ID: 34246825

Collagen‑thrombin topical hemostat achieved effective hemostasis comparable to standard product — hemostasis is an early step that supports wound healing.

PubMed ID: 34418302

Bioactive borate glass matrix markedly improved diabetic foot ulcer healing rates and percent area reduction vs standard care—strong clinical wound‑healing benefit.

PubMed ID: 33872197

Fish-skin grafts healed more treatment‑resistant diabetic foot ulcers than a collagen alginate dressing—clinical wound-healing data involving a collagen comparator.

PubMed ID: 34469077

PMVT allograft outperformed a collagen‑alginate dressing for wound closure and area reduction—relevant to skin healing outcomes (collagen dressing was control).

PubMed ID: 36516059

High‑quality RCT showed oral collagen peptides reduced facial wrinkle scores and eye‑wrinkle volume vs placebo.

PubMed ID: 11074998

Bioengineered bilayer skin (collagen-rich) improved wound healing and skin repair — relevant to improving skin texture post‑injury.

PubMed ID: 28088806

Oral Aloe sterol for 12 weeks increased skin elasticity and ultrasound dermal collagen score—direct improvement in dermal quality and texture.

PubMed ID: 24955642

Randomized 12‑week trial of astaxanthin + collagen hydrolysate showed improved facial skin elasticity and barrier and increased procollagen I mRNA — direct positive skin outcomes though product combined.

PubMed ID: 31627309

RCT showed marked reduction in skin roughness/wrinkle depth with oral collagen peptides.

PubMed ID: 32017646

Randomized trial showed improved dermal collagen structure and subjective moisture/suppleness—direct support for improved texture.

PubMed ID: 28528342

Well‑controlled nutricosmetic containing collagen peptides produced objective increases in skin elasticity and improved skin architecture/texture over 90 days.

PubMed ID: 18086048

Clinical comparison of human collagen filler showed aesthetic improvement of nasolabial folds (wrinkle correction) though of shorter duration vs CaHA.

PubMed ID: 30122200

90‑day multi‑ingredient including hydrolysed fish collagen produced a +40% skin elasticity improvement — supports smoother skin texture though formula mixed.

PubMed ID: 25732262

4‑week oral multi‑ingredient (includes collagen) improved photoaging score and skin hydration — supports smoother texture.

PubMed ID: 31221944

Randomized double-blind oral cartilage extract reduced facial lines/wrinkles and increased skin collagen vs placebo—strong direct evidence.

PubMed ID: 32120787

12‑week randomized trial of fish collagen (with CoQ10/vitamins) showed increased dermis density and reduced periorbital wrinkles—supports improved skin texture, though combination product limits attribution to collagen alone.

PubMed ID: 1345134

Loss of skin collagen with age and its prevention by HRT implies effects on wrinkle formation—directly relevant to collagen-related wrinkle appearance.

PubMed ID: 9366815

Both CO2 laser systems produced clinical skin smoothing with biopsy evidence of new dermal collagen — direct evidence that increased collagen improves skin texture.

PubMed ID: 10687834

HRT increased skin collagen content, a plausible mechanism for improved skin texture in aging skin.

PubMed ID: 10925183

Apligraf (collagen-containing skin construct) improved pigmentation, vascularity and scar pliability—strong evidence for improved skin texture/appearance.

PubMed ID: 12171689

Oral multi-ingredient supplement produced a ~34% reduction in visible wrinkles over 5 weeks — notable clinical effect though not collagen-alone.

PubMed ID: 12786700

Randomized cosmetic trial comparing bovine collagen filler to hyaluronic acid directly assesses wrinkle correction (bovine collagen provided correction though less durable than HA).

PubMed ID: 15468406

Artecoll filler gave clear, durable wrinkle filling and superior investigator/subject satisfaction—direct, strong evidence.

PubMed ID: 15096921

Randomized trial: collagen injections (with Botox) improved glabellar wrinkles more and longer than either treatment alone — direct evidence.

PubMed ID: 15012646

PLA injections stimulated collagen formation and improved facial aesthetic scores—supports wrinkle reduction in a filler context.

PubMed ID: 15008861

Broadband light treatment produced histologic increases in dermal collagen and improved skin appearance—direct relevance to texture.

PubMed ID: 15624743

High‑energy LED improved photoaging with increased dermal collagen and clinical skin appearance in most patients.

PubMed ID: 15622265

Direct cosmetic trial: bovine collagen filler produced temporary wrinkle correction (less durable than HA).

PubMed ID: 16060712

Daily tretinoin cream produced clinically improved wrinkles and increased procollagen synthesis in photodamaged skin.

PubMed ID: 15654716

LED treatment increased skin collagen I and measurably improved surface texture in photoaged patients (histology + topography).

PubMed ID: 16936546

ArteFill (bovine collagen + PMMA) provided durable wrinkle correction with clear clinical improvement—direct evidence for wrinkle reduction.

PubMed ID: 16989189

LED therapy improved wrinkles and increased collagen fiber thickness in photodamaged skin (small open study).

PubMed ID: 17515510

Topical retinol produced clinically significant fine‑wrinkle improvement and increased procollagen I—supports wrinkle reduction via collagen synthesis.

PubMed ID: 17566756

LED phototherapy produced objective wrinkle reductions and increased dermal collagen—supports reduced wrinkle appearance.

PubMed ID: 17338681

Autologous fibroblast injections produced significant and lasting cosmetic improvements associated with increased dermal collagen, reducing wrinkle/defect appearance.

PubMed ID: 18086061

Randomized trial showed porcine collagen filler produced similar 6‑month nasolabial wrinkle improvement to hyaluronic acid — direct evidence for wrinkle reduction using collagen filler.

PubMed ID: 18547179

Porcine collagen filler produced durable correction of nasolabial wrinkles in most patients up to 12 months—strong direct evidence.

PubMed ID: 19083502

Bovine collagen filler corrected wrinkles but with shorter duration vs HA fillers—direct but less durable effect.

PubMed ID: 19013239

Topical DHEA increased expression of multiple collagen genes in human skin—molecular support for improved dermal structure/smoothing.

PubMed ID: 18811602

Low-dose oral isotretinoin increased dermal collagen content and improved clinical photoaging signs (texture/wrinkles/color) in middle-aged women — direct collagen-related skin texture improvement (drug intervention, not collagen supplement).

PubMed ID: 18986859

Porcine/bovine collagen fillers reduced wrinkles and increased lip volume — direct clinical effect of collagen-based filler products.

PubMed ID: 20041778

Oral red ginseng–containing mix improved facial wrinkles and increased dermal type I procollagen expression (objective improvement reported).

PubMed ID: 19496838

Topical collagen tripeptide formulation improved skin roughness and objective skin surface measures in sensitive skin.

PubMed ID: 19735512

Collagen filler (Zyplast) produced meaningful wrinkle correction maintained through 24 weeks in darker-skinned subjects.

PubMed ID: 19522983

Study reported reduced facial wrinkles and increased procollagen type I expression after squalene supplementation — direct wrinkle improvement signal via collagen modulation.

PubMed ID: 20159311

Human collagen injections reduced nasolabial wrinkle severity clinically (direct, strong evidence for wrinkle reduction via filler).

PubMed ID: 21692860

Clinical testing of GEKG tetrapeptide showed significant decreases in facial wrinkle surface roughness versus placebo—direct evidence for reduced wrinkles.

PubMed ID: 21701333

Avotermin (TGF-β3) improved scar appearance and normalized collagen organization on histology after scar revision.

PubMed ID: 21269351

Percutaneous collagen induction (microneedling) produced large, clinically meaningful improvement in atrophic acne scars (skin texture remodeling).

PubMed ID: 21460676

Human collagen filler produced clear early improvement in nasolabial fold appearance compared with baseline (cosmetic reduction of wrinkles).

PubMed ID: 21719865

Direct clinical data: injectable human collagen produced strong early improvement in nasolabial fold appearance (reduced wrinkles), although the effect waned by 13 months.

PubMed ID: 22640000

Combined percutaneous collagen induction + fractional laser produced substantially greater scar improvement (~78%) than either alone — strong evidence of dermal remodeling improving texture (procedural).

PubMed ID: 22409385

Randomized injection of patients' cultured fibroblasts increased dermal collagen and produced statistically significant improvement in nasolabial fold wrinkles vs placebo at 6 months (direct evidence).

PubMed ID: 24401291

Large double‑blind RCT (Verisol®) showed ~20% reduction in eye wrinkle volume vs placebo — strong direct evidence.

PubMed ID: 23949208

Placebo-controlled trial reported improved skin elasticity (interpreted as increased firmness) after oral collagen hydrolysate.

PubMed ID: 24286286

Red/NIR photobiomodulation improved profilometric skin roughness and increased intradermal collagen density — objective smoothing of skin surface.

PubMed ID: 24131075

Oral collagen peptides produced statistically significant improvements in skin hydration and elasticity in an RCT — translates to smoother texture.

PubMed ID: 23340440

Hyaluronic acid filler increased procollagen and related markers and is associated with clinically smoother/less wrinkled skin in the trial.

PubMed ID: 23927381

Oral multi‑ingredient drink produced ≈10% reduction in wrinkle depth and increased dermal collagen on biopsy — direct clinical improvement in wrinkles (product not collagen‑only).

PubMed ID: 23725301

Topical dissolved‑oxygen dressing increased collagen I and elastin while reducing MMPs and improved skin hydration—directly supports smoother texture.

PubMed ID: 23568622

Topical 1‑carbamimidoyl‑L‑proline significantly improved crow's feet appearance and skin roughness vs placebo in 126 women — clear wrinkle benefit (topical agent).

PubMed ID: 23377324

Radiofrequency trial showed high rates of visible hand-skin tightening, consistent with increased firmness via collagen remodeling.

PubMed ID: 24725475

PMMA-collagen injections improved atrophic acne scars in ~64% vs 33% saline—clear improvement in skin texture.

PubMed ID: 25473212

Porcine collagen filler produced meaningful 12-month improvement in nasolabial fold severity—direct, strong cosmetic collagen effect.

PubMed ID: 24946965

Human dermal collagen substitute improved scar elasticity and blinded scar appearance — translates to smoother/ improved skin surface quality.

PubMed ID: 25514823

Noninvasive facial procedures increased TGF‑β and new collagen production in skin biopsies — mechanism for smoother texture.

PubMed ID: 25272190

Clinical trial: porcine atelocollagen dermal filler significantly reduced nasolabial wrinkle severity through 6 months.

PubMed ID: 25006854

PRP, TCA and needling+PRP significantly improved acne scars and appearance — clear benefit to skin texture.

PubMed ID: 25752195

Reported improvement in age spots/photodamage (more even pigmentation) with topical NF‑κB inhibitor.

PubMed ID: 25687834

Acellular collagen dermal matrix improved skin structure/function after burns — supports improved texture.

PubMed ID: 26419871

Collagen carrier with cultured epidermal cells improved long-term scar appearance and elasticity (objective skin texture improvement).

PubMed ID: 26561784

Oral hydrolysed collagen peptides reduced skin waviness and improved dermal density (direct evidence for improved skin texture).

PubMed ID: 26053202

Use of collagen-containing scaffolds in acute wounds influenced regenerated dermis thickness and fibrosis, relevant to skin texture outcomes.

PubMed ID: 26147455

PRP increased dermal collagen and improved appearance of striae—supports collagen increase leading to improved skin texture (though not oral collagen).

PubMed ID: 27168267

Topical stem‑cell secretions increased skin collagen I and improved visible signs of aging, including texture.

PubMed ID: 28508697

Topical estradiol and genistein markedly increased facial type I/III collagen in postmenopausal women, a direct correlate of skin firmness.

PubMed ID: 28915283

Topical serum increased HA and collagen I gene expression and improved skin quality over 12 weeks (instrumental skin-quality improvements).

PubMed ID: 28595250

Hyaluronic acid filler RCTs produced sustained wrinkle improvement and documented increased local collagen synthesis — strong direct support for wrinkle reduction via collagen stimulation.

PubMed ID: 29949889

RCT showed significant wrinkle reduction with oral collagen peptide versus placebo (visual and instrument measures) — strong evidence.

PubMed ID: 30057908

BoNT-A (with intradermal delivery/nanomicroneedle) increased dermal collagen and skin elasticity and reduced crow's-feet wrinkle severity.

PubMed ID: 32269011

SVF‑enriched fat grafting produced significant improvements in VISIA wrinkle and texture scores and increased collagen content in skin.

PubMed ID: 30829779

Collagenase injections for cellulite produced significant clinician/patient‑rated improvement in cellulite severity → smoother body/skin contours and texture.

PubMed ID: 30807389

PMMA‑collagen gel plus microneedling produced clinically better acne scar improvement vs microneedling alone (direct improvement in texture).

PubMed ID: 30834689

Oral hydrolyzed collagen improved dermal echogenicity and reduced pores over 90 days → supports smoother skin texture.

PubMed ID: 32799362

Randomized triple‑blind RCT of oral fish collagen showed significant reductions in facial wrinkle scores vs placebo.

PubMed ID: 32530124

Fish-collagen + Djulis reported ~29% wrinkle improvement and crow's-feet changes in an 8-week RCT—direct evidence for wrinkle reduction.

PubMed ID: 32009486

Double-blind RCT found rapid and lasting improvements in measured skin elasticity after oral collagen hydrolysate (strong direct evidence for firmness).

PubMed ID: 32195722

Collagen-peptide increased skin elasticity (R2) in older adults—consistent with firmer skin.

PubMed ID: 32574009

Retinol serums produced histologic signs of new collagen and thicker epidermis comparable or superior to tretinoin — supports wrinkle reduction.

PubMed ID: 32108322

Plasma gel ± microneedling improved atrophic acne scars and increased collagen/elastin on histology — clinically smoother texture.

PubMed ID: 32333512

Laser + PRP or HA increased collagen/elastic fibers and improved acne scars on biopsy — supports improved skin texture via collagen remodeling.

PubMed ID: 34443468

90‑day RCT of oral hydrolyzed fish cartilage reported frontal −14%, nasolabial −31%, periorbital −26% wrinkle reductions — direct evidence.

PubMed ID: 34009520

Single fractional CO2 session produced ~32–36% periocular wrinkle improvements and increased collagen III — procedural increase in collagen relates to wrinkle reduction.

PubMed ID: 34265165

Coffee pulp extract improved skin moisture, elasticity and brightness and increased measured skin collagen content—clinical improvement in texture metrics.

PubMed ID: 34636463

Reported reductions in crow's feet (~21.8%) and wrinkles (~11.0%) alongside increased skin collagen-content.

PubMed ID: 34246197

αCT1 peptide altered scar collagen organization toward unwounded skin architecture — clinically relevant to improving scar texture.

PubMed ID: 34468410

Microneedling and fractional CO2 laser increased collagen and improved traumatic facial scars — meaningful texture improvement via neocollagenesis.

PubMed ID: 34658151

Nd:YAG + bleomycin improved keloid/scar appearance with histologic collagen changes — relevant to smoothing scarred skin.

PubMed ID: 35781692

Porcine collagen matrix increased buccal soft‑tissue thickness (though less than autograft) — demonstrates collagen's capacity to augment tissue thickness (proxy for firmness).

PubMed ID: 36029335

Xenogeneic collagen matrix increased peri‑implant soft tissue thickness vs baseline (smaller gain than SCTG) — supports connective tissue augmentation.

PubMed ID: 36286457

Topical blue‑shark collagen gel improved skin hydration and texture and reduced wrinkle appearance in a human cosmetic test.

PubMed ID: 36183506

Procedural treatments increased local type III collagen on histology and improved tissue appearance (firming effect).

PubMed ID: 37822045

Well‑designed RCT showing significant reductions in skin roughness and multiple wrinkle metrics with collagen peptides vs placebo.

PubMed ID: 36916504

Oral collagen peptide RCT reported significant reduction in wrinkling by week 12 (direct, randomized evidence).

PubMed ID: 37970760

RCT showed a measurable increase in skin elasticity (Cutometer R2) with enriched low‑MW collagen peptides — supports firmer skin.

PubMed ID: 37683065

Randomized, double‑blind trial showed topical product increased skin firmness and dermal collagen/elastin markers vs vehicle.

PubMed ID: 38931263

Double‑blind RCT: 5 g hydrolysed collagen + vitamin C significantly increased dermis density and reduced roughness and wrinkle volume at 16 weeks.

PubMed ID: 39143887

Oral 5 g collagen peptides improved dermal density, hydration and elasticity vs placebo, consistent with smoother skin texture.

PubMed ID: 39075819

Well-powered RCT of tuna collagen peptides showed large improvements in skin hydration, elasticity and density—strong evidence for smoother texture.

PubMed ID: 39034504

Micro‑focused ultrasound produced measurable brow elevation and visible skin tightening with expected collagen remodeling — direct procedural evidence for increased firmness.

PubMed ID: 39630663

Topical product (ReFORM & RePAIR) increased collagen and improved barrier/DEJ structure vs comparator — translated to improved skin histology and texture; direct topical/biologic evidence (not oral collagen).

PubMed ID: 39069843

Adapalene/BPO produced large biopsy-proven increases in skin collagen/elastin with correlated clinical scar improvement — strong evidence that collagen induction improves skin texture (topical retinoid intervention).

PubMed ID: 39119663

Topical eye cream increased dermal collagen/elastin markers and produced rapid, measurable improvement in periorbital skin (instrumental and clinical endpoints).

PubMed ID: 39334942

Plant meristem extract serums increased dermal hydroxyproline and improved skin elasticity/hydration in menopausal women—objective collagen marker and skin physiology improvements.

PubMed ID: 38299745

Injectable collagen for tear‑trough gave better deformity scores and reduced Tyndall effect vs HA (direct aesthetic texture effect).

PubMed ID: 39161108

Topical ferment lotion trials reported reduced wrinkles and increased collagen marker (pilot human data).

PubMed ID: 38236440

Home device increased dermal type I collagen and clinical skin‑aging measures (device‑induced collagen increase improves texture).

PubMed ID: 38773827

Ultherapy produced measurable lifting and evidence of collagen remodeling consistent with firmer skin.},{

PubMed ID: 38926250

Topical supramolecular salicylic acid increased dermal collagen density and elasticity and improved photoaging scores (direct improvement in texture).

PubMed ID: 38943685

Microneedle RF + bFGF increased collagen and improved acne scars vs RF alone (measurable improvement in texture/scarring).

PubMed ID: 40935395

Randomized trial of oral low‑MW collagen peptide showed consistent, early and sustained improvements in wrinkle measures, elasticity and dermal density—strong evidence for improved skin texture.

PubMed ID: 40518844

Clinical trial reported improvements in firmness/elasticity and fibroblast upregulation of type I procollagen with collagen oligopeptides.

PubMed ID: 41311286

12-week oral collagen peptides increased skin moisture and dermal density and reduced TEWL—objectively improves skin quality/texture.

PubMed ID: 41208340

Intradermal recombinant type III collagen gave large, significant wrinkle improvements versus control (high clinical efficacy at 90 days).

PubMed ID: 40804548

Bovine collagen filler combined with BTX-A produced substantially greater investigator- and patient-rated wrinkle improvement.

PubMed ID: 40586182

Cyclized hexapeptide-9 produced large, statistically significant reductions in crow's feet and forehead wrinkle area vs controls.

PubMed ID: 40662320

PLLA injections reduced striae volume/area and increased type III collagen and elastic fibers (smoother skin contour/textural change).

PubMed ID: 41138781

Oral porcine placental peptides reduced wrinkle depth vs placebo in a randomized trial (oral peptide benefit on wrinkles).

PubMed ID: 40806423

Plant‑based collagen alternative reduced wrinkles and improved elasticity in a placebo‑controlled trial.

PubMed ID: 40296541

Acupotomy + HA improved neck line scores and patient GAIS, with increased measured collagen.

PubMed ID: 40396558

PRP + microneedling produced substantially greater melasma improvement than microinjections (direct pigmentation benefit from a dermal intervention).

PubMed ID: 40069407

Fractional CO2 laser improved scar appearance with histologic increases in collagen/elastin and VSS improvements (texture).

PubMed ID: 40425884

Large randomized multicenter trial: intradermal collagen injections improved skin texture, fine lines and dullness vs control.

PubMed ID: 41215693

Reported significant reductions in wrinkle volume across multiple facial sites (forehead, crow's feet, nasolabial folds) after 8 weeks.

PubMed ID: 40536647

CO2 laser produced histologic collagen remodeling and improved scar texture—relevant to interventions that improve skin texture.

PubMed ID: 41347603

Randomized trial showed larger short‑term reductions in melasma severity with added microneedling/postbiotic/collagen‑mask vs IPL alone (direct effect on pigmentation/skin tone).

PubMed ID: 41454456

Collagen dermal filler delivered superior immediate aesthetic improvement of nasolabial folds vs HA (direct wrinkle reduction).

PubMed ID: 19635616

Prevention of bone loss (spine/hip BMD) and reduced turnover markers can contribute to healthier aging via fracture risk reduction.

PubMed ID: 19013239

Topical DHEA increased expression of multiple collagen genes in postmenopausal skin—molecular evidence relevant to dermal aging processes.

PubMed ID: 17566756

LED phototherapy increased dermal collagen/elastic fibers and improved wrinkles/elasticity—direct skin anti‑aging effects via collagen increase.

PubMed ID: 17515510

Topical retinol increased procollagen I and improved fine wrinkles in aged skin—supports collagen matrix restoration relevant to skin aging.

PubMed ID: 16936546

ArteFill (bovine collagen + PMMA) provided long‑lasting wrinkle correction—durable aesthetic anti‑aging effect though not an oral supplement.

PubMed ID: 11836043

HRT lowered bone-collagen breakdown markers in postmenopausal women—relevant to maintaining bone health with aging.

PubMed ID: 11497535

Improved BMD and reduced bone collagen breakdown in frail elderly women supports healthier aging-related skeletal outcomes.

PubMed ID: 10687834

Hormone replacement increased skin collagen content (~+6.5% over 6 months) — a direct tissue effect relevant to skin aging.

PubMed ID: 10629263

Collagen-matrix skin graft markedly accelerated ischemic wound healing — restorative effect on skin integrity relevant to aging tissue repair.

PubMed ID: 1345134

Direct measurement: skin collagen declines with age/menopause and HRT prevented the decline—highly relevant to aging-related collagen loss in skin.

PubMed ID: 31221944

Oral chicken sternal cartilage increased skin collagen/elasticity and reduced wrinkles—cosmetic/structural benefits relevant to aging appearance.

PubMed ID: 29337906

BMD increases in older postmenopausal women imply a benefit for skeletal health as part of healthy aging.

PubMed ID: 25314004

Collagen-containing supplement attenuated bone loss in older osteopenic women — outcome relevant to healthy aging.

PubMed ID: 16076919

Alendronate increased BMD in postmenopausal women — supports skeletal health component of healthy aging.

PubMed ID: 15952402

Large effects on bone density and collagen-resorption markers support aspects of healthy aging (lower fracture risk surrogate).

PubMed ID: 15031343

Alfacalcidol increased BMD and reduced bone markers in renal patients — supports bone maintenance in older/ill patients.

PubMed ID: 15068495

Clodronate halved vertebral fractures over 3 years — clinically significant for aging populations.

PubMed ID: 14962813

Raloxifene reduced bone turnover and fracture risk markers — relevant to preserving musculoskeletal health with aging.

PubMed ID: 15562367

Alendronate + Ca/VitD reduced bone resorption and preserved BMD in HIV patients with osteopenia — relevant to maintaining bone health.

PubMed ID: 15231012

Continuing alendronate maintained BMD and suppressed turnover vs stopping — relevant for long-term bone health.

PubMed ID: 15380045

HRT improved BMD and biomarkers in postmenopausal RA patients — supports musculoskeletal health in aging.

PubMed ID: 13678775

Large, sustained BMD gains with neridronate support preservation of musculoskeletal health during aging.

PubMed ID: 14500804

Parathyroid hormone increased trabecular bone density and formation markers—an anabolic effect that may counter age-related bone loss.

PubMed ID: 13678475

Large postmenopausal trial demonstrating robust BMD and turnover-marker improvements with alendronate—relevant to maintaining skeletal health with aging.

PubMed ID: 14519796

DASH diet and sodium reduction lowered bone turnover markers—dietary approach with broader cardiometabolic and aging implications.

PubMed ID: 12020302

Hormone therapy produced consistent BMD gains and reduced bone-turnover markers in a large RCT—relevant to age-related bone loss prevention.

PubMed ID: 12459940

Risedronate's strong reductions in collagen-resorption markers and spine BMD gains are relevant to age-related fracture risk reduction.

PubMed ID: 10996576

Calcitonin reduced fractures and modestly increased spine BMD over years — supports age-related fracture prevention.

PubMed ID: 11062356

Alendronate produced meaningful early BMD gains and lowered turnover markers — relevant to healthy aging strategy.

PubMed ID: 10690882

Large RCT showing combinations that preserve BMD and reduce turnover — relevant to healthy aging bone preservation.

PubMed ID: 11000341

Alendronate's marked BMD and marker improvements are applicable to preserving bone health during aging.

PubMed ID: 10550467

Large alendronate trial showing BMD gains supports interventions that help maintain skeletal health with aging.

PubMed ID: 9737352

Vitamin K2 preserved/increased bone density in disused bone, an outcome relevant to age‑related bone loss prevention.

PubMed ID: 9209198

NTx predicted BMD loss and response to HRT in postmenopausal women — important for aging bone health risk stratification.

PubMed ID: 9522323

HRT lowered collagen turnover markers and thus reduces bone loss risk — relevant for menopausal/aging bone health context.

PubMed ID: 39906986

Irbesartan reduced arterial events in vascular Ehlers‑Danlos (collagen III disorder) — meaningful clinical benefit in collagen‑related aging/fragility.

PubMed ID: 23740422

Increased collagen formation and vertebral strength with teriparatide has implications for age‑related bone fragility and functional aging.

PubMed ID: 24131075

Oral collagen peptides improved skin moisture and firmness in a 12‑week RCT — supports aspects of healthy aging (skin appearance).

PubMed ID: 24286286

Photobiomodulation increased intradermal collagen and improved skin appearance — device study but relevant to aging skin.

PubMed ID: 23949208

Oral collagen hydrolysate RCT improved skin elasticity in middle‑aged women — relevant to healthy skin aging.

PubMed ID: 24401291

Oral collagen peptides (Verisol®) RCT produced large increases in procollagen I and elastin and meaningful wrinkle-volume reductions — directly supports dermal anti-aging effects.

PubMed ID: 22465268

Durable BMD gains and reduced turnover can contribute to healthy aging via preserved skeletal health.

PubMed ID: 22791766

Anabolic effects on bone (BMD, PINP) are relevant to age-related bone loss and healthy aging.

PubMed ID: 20861128

Tissue AGEs (crosslinked collagen) associated with poorer diastolic function and lower exercise capacity — relevant to aging-related collagen change.

PubMed ID: 20552330

Four-month lycopene raised antioxidant capacity and reduced collagen resorption marker NTx — may support healthier aging via reduced collagen breakdown/oxidative stress.

PubMed ID: 21164551

Marine collagen peptides improved glycemic control and lipids in T2DM—metabolic benefits relevant to healthy ageing.

PubMed ID: 19858319

Anabolic bone effects of teriparatide may support musculoskeletal health in aging populations.

PubMed ID: 40425884

Large RCT of intradermal collagen injections showing improved skin texture, fine lines and dullness — outcomes associated with perceived healthy aging.

PubMed ID: 40586182

Topical collagen-related peptide improved wrinkles, elasticity and hydration—features associated with healthier skin aging.

PubMed ID: 41311286

Oral collagen peptides improved skin hydration and dermal density—outcomes relevant to visible aspects of healthy aging.

PubMed ID: 40935395

Oral low‑MW collagen peptide improved multiple skin parameters (elasticity, hydration, dermal density) that contribute to an appearance/quality-of-aging.

PubMed ID: 39755603

Multi‑ingredient oral product containing collagen improved pain, function and QoL after meniscal injury—translates to better function/quality metrics relevant to aging.

PubMed ID: 39334942

Topical serums increased dermal hydroxyproline and improved skin hydration/elasticity in menopausal women—supports skin aspects of healthy aging.

PubMed ID: 39119663

Topical eye cream increased collagen/elastin markers and improved periorbital aging signs—direct anti‑aging skin evidence.

PubMed ID: 39291817

Oral collagen peptides (10 g/day ×8 weeks) modestly reduced fatigue and increased vigor and perceived sleep restfulness — directly relevant to subjective aspects of 'healthy aging'.

PubMed ID: 38928934

Daily collagen peptide intake reduced joint pain and improved function—may support mobility and quality of life in aging.

PubMed ID: 39075819

Tuna collagen peptides produced clinically meaningful skin hydration and elasticity gains, supporting age-related skin benefits.

PubMed ID: 38235711

Bovine collagen peptides improved OA symptoms and biomarkers (CTX-II), supporting joint health important in aging.

PubMed ID: 37970760

Low‑MW collagen peptides improved skin elasticity in a randomized double‑blind trial — a marker of healthier aging skin.

PubMed ID: 37245058

Fish collagen peptides reduced skin AGEs and slightly improved insulin resistance—biomarkers relevant to aging processes.

PubMed ID: 35377244

Undenatured type II collagen improved knee ROM in activity‑related discomfort—functional preservation relevant to healthy aging.

PubMed ID: 34636463

Djulis drink increased measured skin collagen and improved several skin-aging measures (moisture, elasticity, fewer wrinkles) — indirect to collagen supplementation but relevant to 'healthy aging' appearance.

PubMed ID: 33677928

Large BMD gains and favorable collagen marker changes are relevant to age-related bone health.

PubMed ID: 34371963

Oral hydrolyzed type II collagen improved joint symptoms/function in adults — may support mobility and function with aging.

PubMed ID: 32799362

Oral fish‑derived collagen improved wrinkle scores and skin elasticity—relevant to cosmetic aspects of healthy aging.

PubMed ID: 30834689

Oral hydrolyzed collagen improved dermis echogenicity and elasticity over 28–90 days, relevant to skin aspects of healthy aging.

PubMed ID: 31126103

Oral collagen peptides (15 g) + resistance training increased fat‑free mass and preserved fat mass in older adults — supports healthier body composition for aging.

PubMed ID: 31859087

Oral hydrolyzed collagen in burn patients improved nutritional marker (pre‑albumin) and greatly accelerated wound healing — indicates supportive effect on recovery and resilience.

PubMed ID: 31010031

Collagen peptide plus resistance training increased fat-free mass and strength—outcomes relevant to healthy aging (muscle preservation).

PubMed ID: 26561784

Oral collagen peptides improved dermal density and skin waviness over 6 months (cosmetic markers relevant to visible signs of aging).

PubMed ID: 25607608

Large BMD gains and reduced collagen breakdown are meaningful for age‑related bone health and fracture risk.

PubMed ID: 26353786

Older men: collagen peptides + resistance training produced greater gains in lean mass and strength — relevant to healthy aging and function.

PubMed ID: 24947034

Topical estrogen in postmenopausal women increased type I collagen and vaginal wall thickness — relevant to aging connective tissues.

PubMed ID: 23775755

Year-long high-impact exercise improved bone mass and physical performance—benefits consistent with healthy aging.

PubMed ID: 22637204

NeoCart collagen‑matrix cartilage implant led to superior pain/function and higher therapeutic responder rates — directly relevant to improved joint motion.

PubMed ID: 22241604

Fibroblast injections in Achilles tendinosis led to improved VISA and VAS function/pain scores, facilitating joint/tendon use.

PubMed ID: 22500661

Oral collagen hydrolysate (1200 mg/day) increased the proportion of patients with clinically meaningful joint pain improvement at 6 months — likely to assist mobility.

PubMed ID: 22486722

BioCell Collagen supplement improved WOMAC and VAS in OA subjects — strong evidence for easier movement/function.

PubMed ID: 21679322

12‑week training increased patellar tendon stiffness and material properties in older adults (tendon/collagen adaptation) which can support improved force transmission and mobility.

PubMed ID: 20401752

Enzymatic hydrolysed collagen improved knee pain and WOMAC function—direct evidence for easier joint movement in OA patients.

PubMed ID: 21139155

Autologous collagen-producing tendon-like cell injections improved tendon pain/function and structure—direct, large effect on mobility-related outcomes.

PubMed ID: 19726771

Collagenase injection substantially improved range of motion in Dupuytren's contracture — direct effect on joint movement.

PubMed ID: 19397687

Intra-articular polymerized type I collagen produced substantial reductions in pain and improved functional scores in knee OA (directly eases movement).

PubMed ID: 19212858

Collagen hydrolysate reduced knee pain and improved joint comfort in OA patients — directly supports easier joint movement.

PubMed ID: 19951408

Oral chicken type II collagen reduced pain and joint counts in RA, improving joint function and movement.

PubMed ID: 19793213

Heavy slow resistance training improved chronic tendinopathy symptoms and tendon collagen turnover, aiding movement.

PubMed ID: 18594088

Collagen meniscus implant increased meniscal tissue and activity in chronic meniscal injury—improves mechanical joint function.

PubMed ID: 18576295

Oral chicken type II collagen improved RA clinical response rates (clinical joint benefit though inferior to MTX).

PubMed ID: 18416885

24‑week oral collagen hydrolysate reduced activity‑related joint pain in athletes, with larger effects in knee‑pain subgroup—supports mobility improvements.

PubMed ID: 16757759

Improved healing of tibial fractures with rhBMP‑2 on collagen sponge would be expected to facilitate joint/limb function after recovery.

PubMed ID: 17009253

Salmon calcitonin improved algofunctional index and reduced cartilage‑degradation markers — consistent with easier joint movement in OA patients.

PubMed ID: 17181919

Intramuscular polymerized type I collagen produced marked improvements in swollen joint counts and disease activity in RA.

PubMed ID: 15855365

Collagen-based cartilage repair improved knee scores and arthroscopic repair quality, implying easier joint movement clinically.

PubMed ID: 14748475

Antiresorptive therapy (alendronate/etidronate) reduced bone resorption markers and improved back pain/ADL in elderly women with vertebral fractures—translates to better mobility.

PubMed ID: 12239666

Collagenase injections for Dupuytren's disease broke down pathological collagen cords and improved finger contractures/movement in most patients.

PubMed ID: 11592359

Low‑dose oral type II collagen gave small but significant improvements in RA activity—supports improved joint function/mobility.

PubMed ID: 10852274

IV clodronate in reflex sympathetic dystrophy produced marked pain reduction and clinical score improvement, which can translate to improved mobility in the affected limb.

PubMed ID: 8546737

Oral bovine type II collagen produced modest clinical responses in some early RA patients—relevant to mobility/joint symptoms.

PubMed ID: 7590814

Anti‑TNF therapy produced marked clinical improvement in RA (reduced swelling/pain) — directly relevant to easier joint movement though not collagen supplementation.

PubMed ID: 8378772

Oral type II collagen produced significant reductions in swollen and tender joint counts in RA patients, consistent with easier joint movement clinically.

PubMed ID: 40561485

Adding collagen to OA regimen produced substantially greater pain/function improvements vs without collagen.

PubMed ID: 37735385

Fish cartilage hydrolysate 3‑month RCT produced large KOOS and pain improvements indicating easier joint movement.

PubMed ID: 33213125

Hydrolyzed collagen II-containing oral mix improved WOMAC/Lequesne and VAS pain after 4 weeks—rapid improvement in joint movement.

PubMed ID: 31381494

Eggshell membrane produced earlier improvements in stiffness and walking—supports easier joint movement.

PubMed ID: 26822714

Well-powered RCT of undenatured type II collagen showed clear improvements in WOMAC and VAS pain in knee OA, translating to better mobility.

PubMed ID: 24189760

Marine bioactive supplement improved symptoms and function faster than glucosamine/chondroitin; relevant to movement.

PubMed ID: 19847319

Undenatured type II collagen (UC‑II) RCT improved WOMAC/ pain/function markedly vs glucosamine+chondroitin in knee OA — strong evidence for easier movement.

PubMed ID: 9856136

Oral chondroitin sulfate RCT improved functional scores in knee OA—relevant to easier joint movement via matrix protection.

PubMed ID: 30122200

Multi‑ingredient liquid with hydrolysed fish collagen improved joint mobility in a 90‑day RCT (confounded by other actives).

PubMed ID: 25848134

Use of a collagen-containing matrix with growth factor produced faster and higher fusion rates in foot/ankle arthrodesis — clinically meaningful improvement in joint surgical outcomes that can ease movement limitations.

PubMed ID: 15380045

HRT reduced cartilage/bone turnover markers (CTX-II/COMP) in RA patients — relevant to cartilage health and joint movement.

PubMed ID: 12854267

Calcium ascorbate reduced pain and improved function (Lequesne score) in OA patients—likely to make joint movement easier in symptomatic OA.

PubMed ID: 40209829

Bovine bioinductive collagen implant reduced rotator cuff retear rate—structural tendon benefit that can preserve/improve shoulder mobility.

PubMed ID: 40237733

Undenatured type II collagen product improved pain/function in knee OA subgroup—strong evidence for easier joint movement.

PubMed ID: 39755603

Multi‑ingredient oral product containing collagen improved pain and multiple function tests (KOOS‑PS, LEFS) in meniscal injury—practical improvements in joint movement.

PubMed ID: 40623147

Collagen peptides improved explosive strength and tendon mechanical properties, which can support functional mobility.

PubMed ID: 38734130

Bioinductive collagen implant RCT produced superior tendon collagen organization, thicker healed tendon and 100% MRI healing — strong direct evidence that a collagen implant improves tendon-related mobility.

PubMed ID: 38562624

Collagen meniscal scaffold led to measurable meniscal volume regeneration vs meniscectomy — supports knee joint structure and potential mobility benefits.

PubMed ID: 10220832

Oral Gly‑X‑Y collagen‑sequence peptides produced some improvement in joint scores in RA patients (functional/mobility signal).

PubMed ID: 38785054

Multi‑ingredient supplement including undenatured type II collagen reduced stiffness/pain and synovitis on MRI—clinically meaningful improvements in joint movement.

PubMed ID: 38551128

Porcine atelocollagen patch at rotator cuff repair markedly reduced 12‑month retear rate — structural benefit likely to support improved shoulder mobility.

PubMed ID: 35512759

Boswellia extract (Aflapin) improved pain and function in knee OA over 30 days—clinical mobility gains though not a collagen supplement.

PubMed ID: 24917648

Collagen scaffold + PEMF after talus surgery resulted in better function and less pain — surgical collagen scaffold associated with easier joint movement postrepair.

PubMed ID: 23043451

Supplement including hydrolyzed collagen reduced pain and improved repair integrity after rotator cuff surgery — relevant to joint function and movement ease.

PubMed ID: 38928934

Specific collagen peptides reduced joint pain during activities and improved functional restrictions vs placebo.

PubMed ID: 38235711

Bovine collagen peptide trial improved OA symptoms and functional scores and reduced cartilage degradation marker (CTX-II).

PubMed ID: 38829812

Undenatured type II collagen RCT improved knee OA pain/stiffness/function—supports easier joint movement.

PubMed ID: 37424319

Collagen peptides plus resistance training increased patellar tendon CSA, an adaptation likely to support joint function and mobility.

PubMed ID: 36918892

Type II collagen produced modest short‑term pain reduction and combined interventions increased muscle strength—supporting joint ease.

PubMed ID: 38158165

Bioinductive collagen implant over rotator cuff repair markedly reduced retear rate, which is likely to improve shoulder function/mobility.

PubMed ID: 37551682

10 g/day collagen peptides improved KOOS ADL and some pain measures in active middle‑aged adults, indicating better function/mobility.

PubMed ID: 35319845

Acupuncture+moxibustion in knee OA decreased collagen‑breakdown markers and improved symptoms — supports easier joint movement.

PubMed ID: 35403756

Specific collagen peptides combined with resistance training increased tendon CSA and muscle thickness — plausible functional mobility benefits.

PubMed ID: 33568038

Oral collagen‑peptide formula (with other actives) plus exercise gave greater and more durable pain/function improvements in chronic low back pain — relevant to mobility.

PubMed ID: 36536333

Collagen injections for partial rotator cuff injury yielded within‑group functional improvements though not superior to comparators.

PubMed ID: 35512781

Low‑dose undenatured type II collagen improved knee flexion and motor function over 12 weeks in healthy participants.

PubMed ID: 35377244

UC‑II produced statistically significant improvements in knee flexion/ROM in active adults with activity‑related knee discomfort—direct evidence for easier joint movement.

PubMed ID: 33794005

Football training improved leg strength and balance, which translates into better mobility (exercise effect, indirect to collagen).

PubMed ID: 34056788

Exercise therapy reduced degenerative‑tissue T2* on UTE MRI and T2* decreases correlated with symptom improvement—objective tissue change linked to better function.

PubMed ID: 33562729

5 g/day collagen peptides reduced activity‑related knee pain in active adults — symptom relief that facilitates easier joint movement.

PubMed ID: 34371963

Hydrolyzed type II collagen produced large reductions in pain and improved function (WOMAC) — directly implies easier joint movement.

PubMed ID: 33904585

Prolotherapy in knee OA improved pain/function and reduced uCTX‑II (cartilage marker) — functional improvement relevant to joint movement (interventional, not oral collagen).

PubMed ID: 34808597

HC+C with training recovered rate-of-force and improved CMJ eccentric metrics — translates to functional mobility improvements in athletes.

PubMed ID: 31010031

Collagen peptide with resistance training increased muscle mass and grip strength—likely to improve mobility/function.

PubMed ID: 31785390

Porcine-derived collagen augmentation of microfracture increased cartilage repair and improved pain/function odds — structural improvements that translate to mobility benefits.

PubMed ID: 31370668

Intra-articular atelocollagen produced clinically meaningful knee pain reduction vs saline, which facilitates easier joint movement.

PubMed ID: 29497287

Eggshell membrane improved exercise-induced joint pain and stiffness and lowered a cartilage-degradation biomarker—supports easier joint movement.

PubMed ID: 29769831

Oral collagen peptides improved subjective ankle function scores (validated) indicating easier joint use in chronic instability.

PubMed ID: 29730208

ACL reconstruction augmented with cartilage fragments (collagen‑rich) improved tendon‑bone integration and reduced tunnel widening — structural benefit relevant to mobility after surgery.

PubMed ID: 29565642

MACI (autologous chondrocytes on collagen membrane) produced better long-term knee pain/function scores vs microfracture (translates to easier joint use).

PubMed ID: 29975270

Collagenase enzymatic injection improved straight-finger outcomes in Dupuytren contracture (directly eases finger movement by degrading pathological collagen cords).

PubMed ID: 29533674

Collagen graft augmentation in rotator cuff repair reduced retears and improved short‑term functional scores — supports easier shoulder movement.

PubMed ID: 29157898

Bioabsorbable collagen implant over rotator cuff tears increased tendon thickness and clinical scores — clinically meaningful mobility improvement.

PubMed ID: 28913600

Collagen‑hydroxyapatite scaffold improved clinical outcomes for osteochondral knee lesions in subgroups — supports improved joint function/mobility.

PubMed ID: 28108777

AMIC (collagen membrane) produced more durable cartilage repair and better function—supports easier joint movement clinically.

PubMed ID: 28177710

Randomized trial: 5 g/day collagen peptides for 12 weeks reduced activity-related knee pain in athletes—likely to improve mobility during activity.

PubMed ID: 27160746

Collagenase injections targeting capsular collagen produced substantial improvements in active shoulder ROM vs exercise — direct evidence that altering collagen affects joint movement.

PubMed ID: 27613719

Group step aerobics improved functional fitness measures in postmenopausal women (direct improvement in mobility/physical function).

PubMed ID: 26905565

Randomized IA porcine collagen injections in knee OA improved pain/function — clinically relevant to mobility improvements.

PubMed ID: 25668399

Progressive impact exercise improved cartilage MRI T2 (collagen integrity) and leg strength in older women—supports mobility via tissue/function improvement (not supplement).

PubMed ID: 25935606

Collagen meniscus implant yielded large functional and pain improvements at 2 years (direct improvement in knee mobility/function).

PubMed ID: 24249841

Resistance training (with or without PEMF) improved joint scores in haemophilia patients — concrete improvement in joint function and movement.

PubMed ID: 23166425

Calcitonin plus exercise improved WOMAC/VAS scores and altered cartilage biomarkers in knee OA, implying easier joint movement and pain relief.

PubMed ID: 22947545

Low‑frequency whole-body vibration improved physical function (balance, walking velocity) in osteoporotic women (functional mobility gains).

PubMed ID: 20401752

Hydrolysed collagen produced clinically meaningful symptom and function improvements in knee OA including stiffness components.

PubMed ID: 19397687

Knee OA trial with intra-articular collagen reduced pain and improved indices that include stiffness measures (strong effect).

PubMed ID: 19212858

Significant OA symptom improvement (WOMAC/VAS) with daily collagen hydrolysate includes reduced stiffness as part of joint symptom relief.

PubMed ID: 19951408

Oral type II collagen reduced tender/swollen joint counts and pain in RA (stiffness typically improved alongside pain).

PubMed ID: 19793213

Resistance training produced lasting symptom relief in tendinopathy including reduced swelling/vascularization—consistent with less stiffness.

PubMed ID: 18416885

Collagen hydrolysate reduced several activity‑related pain parameters that commonly accompany stiffness, particularly for knees.

PubMed ID: 17009253

Function and biomarker improvements in knee OA with salmon calcitonin are consistent with reduced pain/stiffness.

PubMed ID: 17181919

RA trial with polymerized collagen reduced disease activity and joint counts, implying reductions in stiffness.

PubMed ID: 15855365

Both collagen-based cartilage repair techniques produced clinical improvements that would reduce stiffness in the knee.

PubMed ID: 12239666

Collagenase treatment improved contractures and likely reduced stiffness in Dupuytren's patients.

PubMed ID: 11592359

Significant improvement in RA activity at 0.5 mg collagen suggests reduced stiffness in responders.

PubMed ID: 10852274

Clodronate gave dramatic pain and clinical improvements in RSD (often accompanied by stiffness), suggesting reduced stiffness in responders.

PubMed ID: 8546737

Small but measurable clinical benefits in RA study could manifest as reduced stiffness for some participants.

PubMed ID: 7590814

Anti‑TNF therapy led to large clinical improvements in RA, which commonly includes reduced stiffness — directly relevant to this benefit.

PubMed ID: 8378772

RA trial showed decreased tender/swollen joints with oral type II collagen—consistent with reduced stiffness and symptomatic improvement.

PubMed ID: 40561485

Collagen added to regimen led to greater reductions in pain and improved functional scores, implying less stiffness.

PubMed ID: 37735385

Fish cartilage hydrolysate produced large symptomatic relief including pain and function consistent with reduced stiffness.

PubMed ID: 33213125

Small pilot product including hydrolyzed collagen II reduced knee pain and improved functional scores within 4 weeks, including stiffness.

PubMed ID: 31381494

Eggshell membrane led to earlier and clinically meaningful reductions in stiffness (WOMAC subscale), notably in faster responders.

PubMed ID: 26822714

UC-II produced statistically significant reductions in pain and WOMAC including stiffness-related components over 180 days.

PubMed ID: 26905565

IA porcine collagen produced sustained symptom and function improvements in knee OA consistent with reduced stiffness.

PubMed ID: 27160746

Collagenase reduced capsular stiffness in adhesive capsulitis, improving range and symptomatic stiffness (clinical, dose‑dependent effect).

PubMed ID: 28108777

Collagen membrane augmentation of cartilage repair produced sustained functional benefits—likely reduces stiffness by improving joint surface.

PubMed ID: 29533674

Better tendon‑to‑bone healing and lower retear rate after collagen graft likely reduces pain/stiffness and improves function.

PubMed ID: 29975270

Collagenase treatment for Dupuytren contracture reduced finger contracture comparable to surgery, decreasing stiffness.

PubMed ID: 29565642

MACI improved knee pain/function at 5 years vs microfracture suggesting reduced stiffness and better joint performance.

PubMed ID: 29497287

Substantial reductions in immediate and recovery stiffness reported with eggshell-membrane supplementation in an RCT.

PubMed ID: 31370668

Knee pain reduction after intra-articular collagen translates into reduced functional stiffness for many patients.

PubMed ID: 34371963

Significant WOMAC stiffness subdomain improvements after oral collagen II — strong direct evidence.

PubMed ID: 33562729

Collagen peptide RCT reduced activity‑related knee pain which commonly coexists with stiffness — likely to reduce perceived stiffness.

PubMed ID: 34056788

MRI-measured tendon changes associated with symptom improvement after exercise therapy, which often includes reductions in stiffness.

PubMed ID: 35377244

UC‑II improved ROM suggesting reduced stiffness in activity‑related knee discomfort over 24 weeks.

PubMed ID: 35512781

Low‑dose UC‑II decreased knee pain and improved flexibility, consistent with reduced stiffness.

PubMed ID: 35319845

Knee OA RCT showed reduced collagen turnover markers and symptom improvement, consistent with reduced stiffness.

PubMed ID: 37551682

Reported pain/ADL improvements on KOOS suggest reductions in symptoms that commonly include stiffness.

PubMed ID: 38829812

Undenatured type II collagen reduced stiffness in knee OA in a large RCT.

PubMed ID: 38235711

Bovine collagen peptide improved OA stiffness scores and lowered CTX-II, consistent with reduced stiffness.

PubMed ID: 38928934

12-week 5 g collagen peptide intake reduced joint pain and functional limitations, including measures related to stiffness.

PubMed ID: 38551128

Reduced retear rate after atelocollagen patch may reduce chronic stiffness risk, though functional scores were similar at 1 year.

PubMed ID: 38562624

Meniscal regeneration supports joint congruity and may reduce stiffness associated with meniscal deficits.

PubMed ID: 38734130

Superior tendon healing with bioinductive collagen implant should reduce stiffness from tendon pathology and improve joint range.

PubMed ID: 39755603

Post‑treatment improvements in WOMAC/pain and functional scores indicate reduced joint stiffness in meniscal injury cohort.

PubMed ID: 40237733

Artneo improved pain and function in stage‑III knee OA, consistent with reduced stiffness.

PubMed ID: 28056936

In men CS‑OSA produced WOMAC stiffness improvements and reduced cartilage biomarkers—direct evidence for reduced joint stiffness in subgroup.

PubMed ID: 19847319

UC‑II RCT showed large reductions in WOMAC and VAS including stiffness/function vs active comparator.

PubMed ID: 9856136

Chondroitin sulfate produced symptomatic and functional benefits in knee OA including reductions in functional impairment—consistent with reduced stiffness.

PubMed ID: 15380045

HRT lowered cartilage and collagen breakdown markers in RA, potentially reducing stiffness.

PubMed ID: 12854267

Small but significant improvements in pain/function in OA with calcium ascorbate imply reduction in symptoms including stiffness.

PubMed ID: 38785054

Undenatured type II collagen included in multi‑ingredient product produced substantial reductions in stiffness vs comparator—strong clinical effect (product‑level).

PubMed ID: 35512759

Boswellia (Aflapin) markedly reduced pain and stiffness indices in OA patients over 30 days—relevant though not collagen supplementation.

PubMed ID: 23043451

Postoperative pain reduction and improved repair integrity after a collagen‑containing supplement imply decreased stiffness around the repaired joint.

PubMed ID: 26077412

One-year anti-TNF in ankylosing spondylitis produced marked BMD gains and clinical improvements that typically include reduced spinal stiffness and better function.

PubMed ID: 25935606

Large reductions in pain and improved knee function after collagen meniscus implant imply reduced stiffness in many patients (clinical outcome).

PubMed ID: 23486302

Whole‑body vibration added to exercise reduced knee spasticity in chronic stroke patients — relevant to reduced stiffness/spasticity.

PubMed ID: 24249841

Resistance training improved joint function scores; reduction in stiffness contributed to improved joint scores.

PubMed ID: 23166425

Knee OA study reported improved pain/function (WOMAC/VAS) with calcitonin+exercise, consistent with reduced stiffness.

PubMed ID: 22637204

NeoCart showed durable clinical improvement vs microfracture, implying reduced stiffness in treated joints.

PubMed ID: 22500661

Oral collagen hydrolysate produced a higher responder rate for joint pain at 6 months; reduced pain often accompanies reduced stiffness in OA populations.

PubMed ID: 22486722

Significant reductions in pain and WOMAC scores in OA trial imply reductions in stiffness and improved function.

PubMed ID: 20726814

Strontium ranelate reduced urinary CTX‑II over months to years — may reduce cartilage degradation linked to stiffness.

PubMed ID: 21139155

Tendon-targeted collagen-producing cell therapy reduced pain and improved function—likely reduces stiffness associated with tendon pathology.

PubMed ID: 38236440

Home multi‑energy device improved skin hydration and elasticity and increased dermal collagen expression.

PubMed ID: 39161108

Human 28‑day lotion trials (5%/20%) showed marked increases in skin hydration and decreased TEWL alongside increased hydroxyproline (collagen marker).

PubMed ID: 39334942

Serum study showed improved moisture and TEWL alongside increased dermal hydroxyproline—supports hydration improvement.

PubMed ID: 39119663

Topical cream produced rapid and large increases in corneometer hydration and improved skin moisture measures—strong direct hydration evidence.

PubMed ID: 39630663

ReFORM & RePAIR improved collagen, barrier function and TEWL recovery vs comparator — direct evidence for improved skin hydration/barrier integrity.

PubMed ID: 39075819

Tuna collagen peptides produced large, clinically meaningful increases in facial skin hydration and reduced TEWL.

PubMed ID: 39143887

Oral collagen peptides produced significant improvements in skin hydration at 84 days in an RCT.

PubMed ID: 38201966

Randomized placebo‑controlled trial showed improvements in skin hydration (cheek capacitance and dermal hydration) in product arms containing collagen.

PubMed ID: 36916504

Oral collagen peptides significantly improved skin hydration by week 4 in a 12‑week randomized trial (strong direct evidence).

PubMed ID: 37822045

Trial reported significant improvements in skin hydration vs placebo after 12 weeks of collagen peptide supplementation.

PubMed ID: 36286457

Topical shark cartilage collagen acutely increased skin moisture in human cosmetic testing.

PubMed ID: 36516059

Oral collagen peptides significantly increased skin hydration vs placebo in a 12‑week RCT.

PubMed ID: 34636463

Reported skin moisture increased ~13.3% vs baseline — direct hydration improvement signal (though intervention was djulis extract, not collagen supplement).

PubMed ID: 34265165

Coffee pulp drink improved skin moisture vs baseline at 8 weeks (statistically significant change reported).

PubMed ID: 33774639

12‑week RCT: oral collagen peptides increased epidermal/stratum corneum water content, raised NMF and decreased TEWL — strong direct evidence.

PubMed ID: 32195722

10 g/day oral collagen-peptide increased stratum corneum hydration by ~8 units vs control in older adults (RCT evidence).

PubMed ID: 32530124

Fish-collagen + Djulis RCT reported +17.8% skin hydration after 8 weeks (strong direct evidence).

PubMed ID: 31033133

Oral wheat-derived polar lipids significantly improved facial skin hydration in a randomized trial—direct skin hydration outcome (though intervention was not collagen).

PubMed ID: 29949889

Oral low‑MW collagen peptide produced large, statistically significant increases in skin hydration vs placebo in an RCT — high‑quality, direct evidence.

PubMed ID: 28915283

Topical serum produced clear increases in skin hyaluronic acid and objective hydration improvements (TEWL/hydration measures).

PubMed ID: 23725301

Randomized topical dressing trial produced statistically significant increases in skin hydration in healthy volunteers.

PubMed ID: 24131075

Oral collagen tripeptide RCT showed increased skin hydration and decreased TEWL — direct evidence for improved hydration.

PubMed ID: 19496838

Topical collagen tripeptide reduced transepidermal water loss and clinical dryness/irritation scores versus placebo.

PubMed ID: 19013239

Topical DHEA modulated dermal ECM gene expression including components relevant to hydration and dermal matrix integrity.

PubMed ID: 25732262

Oral multi‑ingredient (includes collagen) produced significant increases in measured skin hydration vs placebo in 4 weeks.

PubMed ID: 28528342

Nutricosmetic with collagen peptides produced subjective and objective skin improvements including elasticity; hydration effects often accompany these changes (reported improvements in skin architecture/self‑assessment).

PubMed ID: 32017646

Subjects reported greater skin moisture and suppleness; objective dermal improvements observed.

PubMed ID: 31627309

Large RCT: collagen peptide drink significantly increased skin hydration vs placebo.

PubMed ID: 24955642

Trial reported reduced transepidermal water loss and improved barrier function with astaxanthin + collagen hydrolysate — supports improved hydration/skin barrier, though combined product confounds attribution.

PubMed ID: 40935395

Low‑MW collagen peptide improved objective skin hydration measures versus placebo in an RCT.

PubMed ID: 41311286

Largest direct RCT here: collagen peptides increased skin moisture content and reduced TEWL with durable effects.

PubMed ID: 40804548

Bovine collagen filler with BTX-A improved skin moisture content vs BTX-A alone.

PubMed ID: 40586182

CHP-9 significantly increased skin hydration and decreased TEWL vs vehicle and retinol.

PubMed ID: 41138781

Oral porcine placenta peptides significantly improved skin hydration and reduced TEWL versus placebo in a randomized trial.

PubMed ID: 40806423

Hibiscus‑derived 'collagen alternative' increased measured skin hydration and decreased TEWL in a 12‑week RCT.

PubMed ID: 40425884

Trial showed improvements in skin dryness/dullness after intradermal collagen injections.

PubMed ID: 41215693

Direct trial result: cheek +28% and forearm +25% skin hydration at 56 days (statistically significant).

PubMed ID: 41454456

Collagen dermal filler yielded excellent immediate nasolabial fold correction (aesthetic contouring effect).

PubMed ID: 40662320

PLLA injections decreased striae volume/area and increased type III collagen and elastic fibers, improving body contour of striae-affected areas.

PubMed ID: 41208340

Intradermal recombinant type III collagen improved facial skin appearance (wrinkles/texture/spots), which can translate to improved facial contours/appearance.

PubMed ID: 38085977

Large RCT comparing Cortiva vs AlloDerm reported similar reconstructive failure and patient scores but differential seroma risk—relevant to implant‑based contour/aesthetic outcomes with ADMs.

PubMed ID: 30829779

Large RCT: collagenase injections significantly improved clinician/patient cellulite severity and satisfaction → strong evidence for smoother body contours.

PubMed ID: 32269011

SVF‑enriched fat grafting improved fat graft survival and skin quality, producing better contour and texture outcomes.

PubMed ID: 30866485

Oral skate-derived collagen peptides produced modest body fat reduction over 12 weeks—directly relevant to smoother body contours.

PubMed ID: 26561784

Oral hydrolysed collagen peptides reduced cellulite score and skin waviness and increased dermal density (direct evidence for improved body contours/cellulite).

PubMed ID: 25473212

Porcine collagen filler produced durable nasolabial improvement and contour correction—directly relevant to contour smoothing.

PubMed ID: 24725475

PMMA-collagen improved scar contours vs saline—supports contour improvement in treated areas.

PubMed ID: 22769423

Implantation of acellular dermal matrix after parotidectomy reduced depressed contour deformities — direct surgical evidence of collagen matrix improving contours.

PubMed ID: 22640000

Combined collagen induction and laser gave large scar‑severity improvements (~78%) — can improve surface contour and smoothness of treated areas.

PubMed ID: 12437432

Acellular dermal graft produced greater and longer-lasting increases in lip bulk/projection vs bovine collagen filler—direct improvement in local body/face contour.

PubMed ID: 21460676

Injectable human collagen produced early improvement in nasolabial fold contour (cosmetic contour/smoothing effect).

PubMed ID: 15622265

Bovine collagen filler used for cosmetic correction of facial lines and contours (though less durable than HA).

PubMed ID: 21184067

Collagen‑elastin dermal substitute improved nasal tip contour (aesthetic body contouring outcome) compared with grafts.

PubMed ID: 18547179

Dermal collagen filler maintained cosmetic improvement in nasolabial folds—translates to improved facial contour/appearance.

PubMed ID: 19735512

Collagen filler provided wrinkle correction and contour improvement (nasolabial fold) lasting for months.

PubMed ID: 19793213

Resistance training improved tendon function and likely contributed to improved muscle/tendon unit performance and tone.

PubMed ID: 35403756

Specific collagen peptide (5 g/day) + resistance training significantly increased muscle thickness vs placebo — strong direct evidence for improved muscle tone.

PubMed ID: 36918892

EC‑HC‑II (combination product) increased fat‑free mass and improved grip strength versus comparators—supporting muscle tone gains.

PubMed ID: 40623147

Daily 10 g collagen peptide for 16 weeks increased muscle/tendon stiffness and normalized RTD (explosive strength) without size changes—consistent with improved functional muscle quality/tone.

PubMed ID: 26353786

Collagen peptide supplementation plus resistance training produced significantly greater increases in fat‑free mass and strength in older men.

PubMed ID: 18685526

In resistance‑trained older men, low‑dose creatine + protein increased lean mass and reduced muscle breakdown markers—direct muscle tone benefit (not collagen).

PubMed ID: 31010031

Randomized double-blind trial: specific collagen peptide plus resistance training increased fat-free mass and hand-grip strength vs placebo—strong evidence for improved muscle tone/mass.

PubMed ID: 31126103

Collagen peptide supplementation with resistance training increased fat‑free mass and preserved fat mass vs placebo, consistent with improved muscle tone/appearance.

PubMed ID: 34808597

Hydrolyzed collagen + vitamin C with training improved rate‑of‑force development and jump eccentric metrics — strong functional signal for muscle performance/tone.

PubMed ID: 33946565

15 g/day collagen peptides with resistance training produced significantly greater fat‑free mass gains vs placebo — direct evidence for improved muscle tone/body composition.

PubMed ID: 33794005

Recreational football training improved leg strength (muscle function) — translates to better muscle tone/function (exercise effect).

PubMed ID: 33420277

Whole-body vibration increased eccentric knee extensor work, indicating improved muscle performance/toning.

PubMed ID: 36433662

Randomized trial: collagen peptide supplementation during resistance training produced greater increases in quadriceps and total trained muscle volume (direct, high relevance to tone).

PubMed ID: 15068495

Clodronate significantly reduced vertebral fractures over 3 years — meaningful clinical benefit likely improving vitality.

PubMed ID: 39755603

Multi‑ingredient oral product containing collagen improved QoL (SF‑12 PCS/MCS) and multiple functional measures in meniscal patients—translates to enhanced perceived vitality.

PubMed ID: 39291817

Oral collagen peptides modestly reduced fatigue and increased vigor and perceived sleep restfulness — directly supports improved subjective vitality.

PubMed ID: 32910197

Cardiac scaffold intervention demonstrated safety and small improvements in infarct size and LVEF in low‑function patients — may translate to improved functional vitality.

PubMed ID: 31126103

Improvements in fat‑free mass and preserved fat mass with collagen peptide supplementation + resistance training support better physical function and vitality.

PubMed ID: 31859087

Oral collagen improved nutritional marker (pre‑albumin) and accelerated healing in burn patients — indicates enhanced recovery capacity and overall resilience.

PubMed ID: 26353786

Clinical gains in muscle mass, strength and function with collagen peptide supplementation + training are consistent with improved vitality/functional capacity in older men.

PubMed ID: 23948830

High‑impact exercise increased BMD and improved health‑related quality of life in postmenopausal women — supports broader vitality.

PubMed ID: 20556834

Colchicine reduced procollagen III and was associated with improved survival in chronic liver disease—meaningful overall outcome.

PubMed ID: 20514986

Marine collagen peptides improved inflammatory and metabolic biomarkers (hs‑CRP decreased, adiponectin increased) in T2D—plausibly improving systemic vitality/health.

PubMed ID: 21164551

Metabolic improvements (glucose, HbA1c, triglycerides) after marine collagen peptide intake can contribute to improved vitality/health.

PubMed ID: 24440672

Short‑term budesonide was effective vs placebo for collagenous colitis (improved stool consistency and clinical remission).

PubMed ID: 26776435

Use of a fibrinogen–thrombin collagen sponge during GI anastomosis reduced postoperative intestinal fistulas—direct, clinically relevant gut outcome (surgical context).

PubMed ID: 28275307

Randomized gastric ulcer study: hydrotalcite+esomeprazole markedly increased collagen deposition and hydroxyproline — directly relevant to improved GI mucosal healing/comfort.

PubMed ID: 25425655

Low‑dose oral budesonide maintained remission and QoL in collagenous colitis — clear symptomatic gut improvement (treatment is steroid, not collagen).

PubMed ID: 20676860

Topical bovine type I collagen spray promoted complete healing for anal fissures in children—direct improvement in anorectal comfort/healing.

PubMed ID: 18669576

Budesonide maintenance markedly increased clinical remission in collagenous colitis (improved gut symptoms) — disease explicitly named 'collagenous'.

PubMed ID: 18926826

Oral budesonide maintained remission and reduced relapse in collagenous colitis—direct improvement in gut symptoms for this collagen‑related condition.

PubMed ID: 17565633

Mesalazine (and combination therapy) led to rapid symptom resolution and high remission rates in microscopic/collagenous colitis — direct GI symptom benefit in a collagen-related disease.

PubMed ID: 28668970

Human RCT: intermittent pneumatic compression greatly increased PINP (collagen I) during Achilles tendon healing—biologic support for faster matrix formation/recovery.

PubMed ID: 31126103

Collagen peptide supplementation improved body composition with resistance training; may support recovery/repair though direct recovery metrics were not primary outcomes.

PubMed ID: 34808597

Hydrolyzed collagen + vitamin C with training produced significant recovery of rate-of-force and improved jump eccentric metrics — robust exercise-recovery signal.

PubMed ID: 39755603

Oral product containing collagen improved functional recovery metrics after meniscal injury (pain, function, QoL) over 8 weeks—clinical recovery context.

PubMed ID: 40963202

High‑dose vitamin D before an ultramarathon attenuated bone resorption, supported formation markers and blunted inflammatory responses—evidence of improved acute recovery physiology.

PubMed ID: 37357646

Hydrolyzed fish collagen supplement added to standard hair‑loss drugs produced substantially better global assessment and higher responder rates at 12 weeks.